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Summary 
 
A diverse community of microorganisms that form a complex ecosystem colonizes 
the gastrointestinal tract. This community has been termed the intestinal microbiota. 
The microbiota and their metabolites play a crucial role in the physiology of the host. 
In particular, resident bacteria promote the development and maturation of the 
immune system, but also protect the host against invading enteric pathogens by a 
process called colonization resistance. The intestinal microbiota confers resistance 
directly by producing inhibitory substances and competing for nutrients or indirectly, 
by strengthening the epithelial barrier and enhancing protective immune-mediated 
pathways. Disruption of the resident microbiota, e.g. by medical treatment, is linked 
to higher susceptibility to infections. Moreover, the composition of the microbiota is 
highly variable among humans and these differences may contribute additionally to 
varying susceptibilities to enteric pathogens. Until now, little is known about the 
contributions of individual members of the intestinal microbiota to confer colonization 
resistance. 
To understand how different intestinal microbial communities influence the 
susceptibility to enteric pathogens, isogenic mouse lines from different breeding 
facilities were analyzed regarding their microbiota composition. Subsequently, mouse 
lines were challenged with Salmonella Typhimurium (non-typhoidal model) and 
Citrobacter rodentium to identify microbial signatures associated with decreased 
disease severity.   
Analyzing the fecal microbiota by 16S rRNA gene amplicon sequencing revealed that 
isogenic mouse lines from different breeding facilities featured a distinct microbiota 
composition. Moreover, isogenic mouse lines displayed different susceptibilities to S. 
Typhimurium infection. Fecal transplantation from resistant to susceptible mice 
reproduced the protected phenotype. Statistical analysis of 16S rRNA sequencing 
data identified bacteria of the families S24-7, Prevotellaceae and 
Verrucomicrobiaceae to be associated with increased resistance. Transfer of 11 
bacterial species, cultured from protected mice, in susceptible mice diminished 
disease severity. Interferon-γ was identified as novel microbiota modulated factor 
and demonstrated that it is required for conferring resistance through immune-
mediated colonization resistance.   
In addition, isogenic mouse lines with different microbiota composition varied in their 
susceptibility to Citrobacter rodentium infection. By using cohousing experiments of 
susceptible and resistance mice coupled with statistical analysis of 16S rRNA 
sequencing data, two bacteria of the family Lachnospiraceae were identified 
important to diminish luminal colonization.  
The results highlighted that differences in the microbiota of immunocompetent mice 
influence the outcome of enteric infections. Moreover, novel microbial signatures and 
mechanisms were identified to confer resistance to S. Typhimurium and C. rodentium 
infections. Characterization of microbial interactions and metabolites as well as the 
corresponding immune factors that influence host physiology are important 
contributions that may enable developing improved therapies for mucosal infections. 
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Zusammenfassung 
 
Eine vielfältige Gemeinschaft von Mikroorganismen kolonisiert den 
Gastrointestinaltrakt und bildet dort ein komplexes Ökosystem. Diese Gemeinschaft 
wird als Darmmikrobiota bezeichnet und spielt eine entscheidende Rolle in der 
Physiologie des Wirts. Insbesondere fördern kommensale Bakterien die Entwicklung 
und Reifung des Immunsystems. Darüber hinaus schützen sie den Wirt vor 
Krankheitserregern, was auch als Kolonisationsresistenz bezeichnet wird. Die 
Darmmikrobiota vermittelt dies direkt, indem sie hemmende Substanzen produziert, 
oder indirekt durch die Stärkung der Epithelbarriere und der Förderung von 
protektiven Immunantworten. Die Zerstörung der kommensalen Mikrobiota, z.B. 
durch eine Behandlung mit Medikamenten, geht einher mit einer höheren Anfälligkeit 
gegenüber Infektionen. Außerdem ist die Zusammensetzung der Mikrobiota bei 
Menschen variabel, was Unterschiede im Krankheitsverlauf von Enteropathogenen 
erklären könnte. Bisher ist nur wenig darüber bekannt, ob und wie die einzelnen 
Mitglieder der Darmmikrobiota zu der Kolonisationsresistenz beitragen. 
Um zu verstehen, wie verschiedene mikrobielle Gemeinschaften die Anfälligkeit des 
Wirts gegenüber Enteropathogenen beeinflussen, wurden isogene Mauslinien 
verschiedener Züchtungseinrichtungen hinsichtlich ihrer Mikrobiotazusammen-
setzung analysiert. Anschließend wurden Mauslinien mit Salmonella Typhimurium 
(nicht-typhoides Modell) und Citrobacter rodentium infiziert, um Bakterien zu 
identifizieren, die den Schweregrad der Erkrankung positiv beeinflussen.  
Die Analyse der Mikrobiota mittels 16S-rRNA-Sequenzierung ergab, dass isogene 
Mauslinien aus verschiedenen Züchtungseinrichtungen eine unterschiedliche 
Zusammensetzung der Mikrobiota aufweisen. Außerdem zeigten isogene Mauslinien 
unterschiedliche Anfälligkeiten gegenüber Infektionen mit S. Typhimurium. Eine 
Stuhltransplantation bildete in anfälligen Mäusen den geschützten Phänotyp nach. 
Die statistische Analyse von 16S-rRNA-Sequenzierungsdaten zeigte, dass Bakterien 
der Familien S24-7, Prevotellaceae und Verrucomicrobiaceae mit einer erhöhten 
Resistenz assoziiert sind. Die Übertragung von 11 bakteriellen Spezies, die aus 
geschützten Mäusen kultiviert wurden, verminderte bei anfälligen Mäusen die 
Schwere der Erkrankung. Interferon-γ wurde als neuartiger Mikrobiota-modulierender 
Faktor identifiziert. Es konnte gezeigt werden, dass Interferon-γ für den Transfer der 
immun-vermittelten Kolonisationsresistenz erforderlich ist. 
Außerdem zeigten isogene Mauslinien, die eine unterschiedliche Zusammensetzung 
der Mikrobiota aufweisen, eine unterschiedliche Anfälligkeit gegenüber C. rodentium 
Infektion. Unter Verwendung von Cohousing-Experimenten von anfälligen und 
resistenten Mäusen, die gekoppelt wurden mit einer statistischen Analyse von 16S-
rRNA-Seqeuenzierungsdaten, wurden zwei Bakterien der Familie Lachnospiraceae 
identifiziert, die mit verringerter luminalen Kolonisation assoziiert sind. 
Die Ergebnisse dieser Arbeit konnten zeigen, dass Unterschiede in der Mikrobiota 
den Schweregrad von Darminfektionen bei Mäusen beeinflussen. Zudem wurden 
neue mikrobielle Signaturen und Mechanismen identifiziert, die mit Resistenzen 
gegenüber Infektionen mit S. Typhimurium und C. rodentium assoziiert sind. Die 
Charakterisierung der mikrobiellen Wechselwirkungen und Metaboliten, sowie die 
entsprechenden Immunfaktoren, welche die Wirtsphysiologie beeinflussen, sind 
wesentlich, um verbesserte Therapien für mukosale Infektionen zu ermöglichen. 
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General introduction 
 
The gastrointestinal tract harbors a vastly diverse and dense microbial 
community, termed as microbiota (Ley et al., 2008). Different species of 
bacteria intimately interact with the gut tissue, contributing significantly to the 
physiology of the host (Guinane and Cotter, 2013). Especially in the last 
years, new sequencing techniques contributed greatly to the knowledge about 
the composition and the functionality of the human microbiome in health and 
disease (D'Argenio and Salvatore, 2015). Moreover, researchers have shed 
light on the influence of the complex interactions of the microbiota with the 
mammalian host, which is a result of coevolution, termed as mammalian 
holobiont.  
MICROBIOTA PATHOGEN 
HOST  
IMMUNE SYSTEM 
Colonization resistance 
Exploitation of the 
microbiota for colonization 
DYSBIOSIS 
Figure 1.1 - Interplay between the microbiota, host immune system and pathogen. In 
the intestine, interaction of microbes with host immune cells are crucial for the development 
of a proper immune system as well as its activation. In turn, cells of the immune system 
control the microbiota composition contributing to a healthy gut homeostasis. Under 
homoestatic conditions, the microbiota confer colonization resistance against invading 
enteric pathogens. However, during dysbiosis enteric pathogens are able to colonize the 
gastrointestinal tract inducing pathogenicity.  
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Gut bacteria are important for the digestion of food, the provision of specific 
nutrients as well as maintaining structural integrity of the gut mucosal barrier, 
affecting proper development and functioning of the immune system (Belkaid 
and Hand, 2014; Tremaroli and Bäckhed, 2012). Moreover, intestinal bacteria 
of the microbiota compete with pathogenic microorganisms, protecting the 
host against invading pathogens (Bäumler and Sperandio, 2016).  
Microbial colonization of the host occurs right after birth and in the first years 
of life the microbiota increases its diversity (Koenig et al., 2011). Within only 
2-5 years an adulthood-like microbiota is formed and each individual develops 
a relatively distinct, unique at the species level, stable community (Dethlefsen 
and Relman, 2011; Rodríguez et al., 2015).  
Bacteria of the gut microbiota and the immune system contribute together to a 
balanced homeostasis in the gut by creating a mutual relationship (Figure 
1.1). Interaction between the microbiota and the host tissue affect the immune 
system locally and systemically (Clarke et al., 2010). In turn, host immune 
cells have large effects on the composition of the gut microbiota (Friman et 
al., 2002). However, disruption of the intestinal homeostasis leads to 
dysbiosis, an imbalanced shift of the microbial composition. Dysbiosis is 
characterized by a decrease of bacterial diversity and results in dysregulation 
of the host-microbiota interactions. Therefore, dysbiosis augment disease 
susceptibility to gastrointestinal infections (Brandl et al., 2008; Ivanov et al., 
2008; La Cochetière et al., 2008). Alteration of the microbiota composition is 
caused by a variety of factors such as genetic and environmental factors, i.e. 
diet, antibiotic treatment and exposure to pathogenic microbes (Round and 
Mazmanian, 2009). Even among healthy individuals, the diversity of the 
microbial community varies widely (Human Microbiome Project Consortium, 
2012). This could be one reason explaining the huge differences in 
susceptibility to gastrointestinal infections seen among individuals (Yurist-
Doutsch et al., 2014). Experiments with germ-free mice (mice lacking any 
microbiota) and mice with a reduced microbiota diversity have demonstrated 
that they are more susceptible to gastrointestinal pathogens (Bohnhoff and 
Miller, 1962; Inagaki et al., 1996; Reeves et al., 2012). However, it is not fully 
known yet which commensal bacteria are involved in conferring resistance to 
infection with enteric pathogens. Moreover, how these commensal bacteria 
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interact with the pathogen and/or stimulate the immune system to lower 
susceptibility has only started to be understood. Detailed knowledge about the 
interactions between the microbiota, the host and invading pathogens would 
potentially allow the development of new mucosal therapies against enteric 
infections. 
The main aim of this work is to identify bacterial signatures, which correlate 
with decreased susceptibility to gastrointestinal infections, i.e. to Salmonella 
enterica serovar Typhimurium and Citrobacter rodentium. In addition, this 
work strives to gain more insight into the interplay between the microbiota and 
the immune system to confer resistance to enteric pathogens.  
 
1.1 The mucosal immune system in the intestine 
 
The gastrointestinal tract is constantly exposed to a vast amount of different 
antigens, including infectious agents but also harmless materials, i.e. food 
antigens or commensal bacteria. Cells and molecules of the mucosal immune 
system support the intestinal barrier function, the physical barrier in the gut. 
But, antigens can breach the mucosal epithelium and easily be transported 
across it. Therefore, the mucosal immune system has to control tightly 
immune responses to these antigens and distinguish innocent materials and 
potentially harmful agents. In particular, the mucosal immune system has to 
avoid raising strong immune responses against a broad range of harmless 
material, whereas it has to induce an effective protective immune response 
against invading pathogens. How the host organizes these different 
requirements, will be discussed in the following.  
Antigens activate different branches of the mucosal immune system. The 
mucosal immune system is divided in two parts: the innate and adaptive 
immune system. The innate immune system is composed of cells and 
proteins that are ready to mobilize and therefore, able to provide an 
immediate, but non-specific response to infectious agents. The innate 
response activates the adaptive immune system including two different 
lymphocytes, T- and B-Lymphocytes. Unlike the innate immune response, the 
adaptive immune response is highly specific to a particular pathogen and 
creates long-lasting immunological responses. Both, the innate and adaptive 
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immunity contribute with the microbiota to intestinal homeostasis and are 
crucial for conferring colonization resistance against pathogens.  
As already mentioned, the mucosal immune system encounters a wide range 
of antigens. Therefore, the intestinal epithelial cells (IEC) have to provide a 
degree of permeability, so that the uptake of essential nutrients and fluids is 
guaranteed. In turn, IECs have to separate the underlying mucosal tissue 
from potential pathogens. Additionally, the barrier function of IECs is 
supported by secretory glycoproteins produced by goblet cells, which form a 
viscous layer on the intestinal surface, known as mucus layer. In the small 
intestine, the mucus layer consists of a single layer, but it is composed of two 
layers in the stomach and colon. The dense inner mucus is firmly attached to 
the apical epithelial cells and is largely sterile; whereas the looser outer layer 
tolerates endogenous bacteria, which use mucus as carbon source 
(Johansson et al., 2011; 2008; Li et al., 2015). Besides mucus production, 
intestinal epithelial cells (IEC) support barrier function by producing 
substances, which are microbicidal or prevent microbial growth such as 
lysozymes and antimicrobial peptides (e.g. defensins, cathelicidins, histatins) 
(Muniz et al., 2012). Strikingly, the largest fraction of immune cells of the body 
is found throughout the intestine, localized interspersed with IECs or 
immediately below IECs in the lamina propria (LP). Immune cells can be 
found scattered in the tissue and organized in lymphoid structures, such as 
Peyer’s patches (PP), isolated lymphoid follicles (ILFs) and cryptopatches. In 
particular, PPs and ILFs are specialized to uptake antigens from the lumen via 
microfold cells (M cells) by transcytosis (Gebert et al., 2004; Owen and Jones, 
1974) (Figure 1.2). M cells are specialized epithelial cells, which lack the 
ability to secrete mucus and enzyme, though are more accessible than 
enterocytes as they transport large volumes of luminal content via pinocytosis 
(Mabbott et al., 2013).  
After invading the mucosal tissue, bacterial antigens encounter cells of the 
innate immune system. Cellular compartment of the innate immune system 
includes common innate immune cells such as myeloid cells (e.g. DCs, 
macrophages, eosinophils, neutrophils, mast cells) as well as innate lymphoid 
cells (ILCs). Myeloid cells are able to kill bacteria, e.g. via extracellular nets or 
via phagocytosis, and activate the adaptive immune system by cytokine 
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release and antigen presentation. ILCs belong to the lymphoid lineage and 
express a cytokine profile similar to cells of the adaptive immune system. 
However, ILCs display the characteristics of innate immune cells such as the 
lack to generate immunological memory and their activation in early phase of 
immunity (Klose and Artis, 2016).  
 
Figure 1.2 – Organization of the gut associated lymphoid tissue (GALT). The intestinal 
epithelium separates the external luminal environment from the body. Beneath intestinal 
epithelia cells, the lamina propria harbors organized lymphoid follicles (Peyer’s patches and 
isolated lymphoid follicles), which consist of B and T cells as well as resident and migratory 
myeloid cells such as dendritic cells. M cells enable antigen transport form the lumen to the 
lamina propria, activating immune cells in the lymphoid follicles, but also scattered immune 
cells in the lamina propria. In turn, immune cells migrate to the mesenteric lymph node via 
lymphatic vessels. In the lamina propria, mature B cells generate IgA, which is secreted in the 
lumen. AMPs – antimicrobial peptides, DC – dendritic cells, IEL – intestinal epithelial 
lymphocytes, M cell – microfold cell, MΘ – macrophages, sIgA – secreted immunoglobulin A 
 
Myeloid and epithelial cells sense microorganisms through germline-encoded 
molecules, known as pattern-recognition receptors (PRRs), which serve as a 
continuous surveillance system for the host. PRRs recognize microorganisms 
via conserved microbial structures, so called pathogen-associated molecular 
patterns (PAMPs). A vast variety of molecules derived from microorganisms 
function as PAMPs including nucleic acids, proteins, glycans, lipids and 
lipoproteins, The most studied PRRs are Toll-like receptors (TLRs), 
nucleotide-binding oligomerization (NOD)-like receptors (NLRs), retinoic acid-
inducible gene I (Rig I)-like receptors (RLR) and C-type lectin receptors 
(Medzhitov, 2007). PRR signaling is critical for inducing an immune response 
upon recognition of PAMPs. In contrast to pathogens, commensal bacteria of 
Lamina  
propria 
Intestinal  
lumen 
Paneth  
cell 
Goblet 
cell 
M cell 
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sIgA 
Epithelial  
cell 
Micro- 
organisms 
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T cell 
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the microbiota do not trigger inflammatory signaling pathways, but contribute 
to a normal immune function, which is also mediated by PRRs (Kubinak and 
Round, 2012). PAMPs are not only restricted to pathogens, rather than 
present in all microorganisms. Therefore, it was proposed to replace the term 
PAMPs in absence of infections to microbe-associated molecular pattern 
(MAMPs) (Mackey and McFall, 2006).  
After recognizing bacteria by PRRs innate immune cells also activate adaptive 
immune responses. DCs take up antigens that crossed the epithelial barrier 
and PAMPs to initiate a maturation program. Harmless antigens derived from 
food or commensal bacteria do not elicit a systemic immune response, but 
provide tolerance; whereas pathogenic bacteria induce a strong immune 
response. Commensal bacteria do not possess any virulence factors and 
therefore, do not induce inflammation. CD103+ DCs localized in the mucosa 
recognize harmless antigens and transport antigens to the draining 
mesenteric lymph nodes, where they prime a gut-homing phenotype to naive 
T cells (Iwata et al., 2004). After DCs encounter CD4+ T cells, generation of 
forkhead box protein P3 (FoxP3) positive regulatory T cells (Treg) is induced 
(Pabst et al., 2007; Sun et al., 2007). CD103+ DCs also initiate class switching 
of intestinal B cells to IgA (Uematsu et al., 2008). Treg cells and IgA-expressing 
B cells recirculate back to the LP where they undergo secondary expansion 
and ensure local tolerance to harmless antigens. Treg cells produce IL-10 and 
TGF-β, which suppress pro-inflammatory T cell subsets, including TH1 and 
TH17 cells (Harrison and Powrie, 2013). Mucosal IgA, secreted in the gut 
lumen, can neutralize bacteria and toxins, averting tissue adhering and 
induction of an immune response. In addition, IgA also acts in the LP, where 
IgA binds to bacteria, which crossed the epithelial barrier (Mantis et al., 2011). 
In both cases IgA avoids stimulation of the immune system against harmless 
commensal bacteria. Therefore, IgA and Treg cells play a key role in inducing 
tolerance to harmless antigens.  
In contrast to commensal bacteria, pathogenic bacteria possess different 
virulence factors, which induce a strong inflammatory response in the 
intestine by activating different immune pathways. Upon detection by PPRs, 
pathogens elicit production of pro-inflammatory cytokines and attract different 
immune cells such as neutrophils to the site of the infection. Crossing the 
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epithelial barrier, intracellular pathogenic bacteria infect phagocytes, which 
enter the bloodstream, allowing the pathogen to gain access to systemic 
organs (Monack et al., 2004). Moreover, pathogenic bacteria drive the 
development of pro-inflammatory cell subsets, such as TH1 and TH17 cells, 
which are important for combat disease (Damsker et al., 2010). 
Traditionally, pathogenic bacteria are distinct from commensal bacteria due to 
the expression of virulence factors. However, it becomes more and more clear 
that some commensal bacteria share characteristics similar as virulence 
factors in pathogens (Ayres, 2016). Moreover, some commensal bacteria 
have been identified to elicit effector cell differentiation, such as TH1 and TH17 
cells without inducing inflammation and protecting the host to infections 
(Asseman et al., 2003; Ivanov et al., 2009).  
In summary, the mucosal immune system has to distinguish constantly 
between infectious and harmless material to maintain homeostasis in the gut 
as well as to rapidly combat enteric infections. How the mucosal immune 
system differentiates between pathogens and commensal bacteria is 
important to understand the complex microbe-host interaction, but has still not 
been fully understood. 
 
1.2 The microbiota regulates mucosal immune responses 
 
The coevolution between the host and the gut microbiota has created a 
relationship of mutual benefit. The host offers bacteria of the microbiota an 
essential environment (e.g. niches, nutrients) to exist, whereas the microbiota 
composition influences strongly the physiology of the host by modeling the 
mucosal immune system. In turn, genetic deficiencies in important immune 
pathways also affect the composition of the microbiota.   
In the following, I will discuss recent insights into the influence of intestinal 
bacteria on the mucosal immune system. 
 
1.2.1 Impact of the microbiota on the innate immune system 
 
The microbiota has a pivotal role in the maturation of innate immune cells. 
Germ-free mice show decreased numbers of several peripheral innate 
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immune cell populations; including macrophages, neutrophils and monocytes 
(Khosravi et al., 2014). It has been reported that commensal bacteria are 
needed for hematopoietic stem cell (HSC)- and also embryo-derived myeloid 
cell development (Khosravi et al., 2014). Interestingly, fecal transplantation of 
a complex microbiota composition into germ-free mice restores defects in 
myeloid cell development (Khosravi et al., 2014). Specifically, microbiota-
derived short chain fatty acid (SCFA) have been suggested to enhance 
hematopoiesis in the bone marrow (Trompette et al., 2014). But, commensal 
intestinal bacteria and products can also affect the development of myeloid 
cells after haematopoiesis. It has been reported that microbiota-derived SCFA 
modulates the function of macrophages in the LP due to the inhibition of 
histone deacetylases (Chang et al., 2014). The continuous replenishment of 
macrophages in the LP by monocytes expressing C-C chemokine receptor 
type 2 (CCR2) is also dependent on commensal gut bacteria (Bain et al., 
2014). The microbiota has not only a pivotal role in myelopoiesis, but also in 
regulation of ILCs. Differently to myeloid cells, the development of ILCs is 
dispensable of the microbiota, though intestinal bacteria are needed for 
proper functioning of ILCs (Abt et al., 2012; Ganal et al., 2012). For example, 
tryptophan metabolism by intestinal commensal bacteria (e.g. Lactobacillus 
reuteri) leads to maturation of ILCs (Kiss et al., 2011; Lee et al., 2011; Perdew 
and Babbs, 1991). 
However, not only the postnatal microbial colonization is crucial for immune 
cell development, but already the maternal microbiota influences innate 
immune development in the offspring. It has been shown that molecular 
metabolites of the maternal microbiota impact the development of ILCs and 
F4/80+CD11c+ mononuclear cells in utero (Gomez de Agüero et al., 2016).  
Bacteria of the microbiota promote also the epithelial barrier function in the 
intestine. Epithelial cells use microbiota-derived SCFA as energy source, 
which depletes intracellular oxygen through respiration leading to stabilization 
of hypoxia-inducible factor (HIF), a transcription factor important for 
coordinating tissue barrier function (Kelly et al., 2015). Germ-free mice as well 
as antibiotic treated mice showed reduced luminal SCFA levels and therefore, 
exhibit diminished HIF, which is connected to a reduced epithelial barrier 
function (Kelly et al., 2015).  
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Taken together, the intestinal microbiota greatly affects myeloid and lymphoid 
cells as well as epithelial cells, which all are crucial for a proper signaling of 
innate immune cells. Alteration of the microbiota can lead to severe defects in 
the development and functionality of the innate immune system. 
 
1.2.2 Impact of the microbiota on the adaptive immune system 
 
Intestinal bacteria have a crucial role in the differentiation of cell types of the 
adaptive immune system, i.e. influencing the functional diversity and 
repertoire of T and B cells.  This is apparent in germ-free mice that develop an 
immature mucosal adaptive immune system as compared to conventionally 
raised mice, characterized by with fewer germinal centers in PPs as well as 
reduced level of IgA-producing B cells and CD4+ T cells (Macpherson and 
Harris, 2004). In the last decade, researchers provided new mechanistic 
insights into which specific intestinal members participate in the stimulation of 
particular adaptive immune pathways. 
Several studies have identified an influence of intestinal commensals to direct 
the differentiation of naïve CD4+ T cells, e.g. to TH17 cells or Treg cells. TH17 
cells are a subclass of T helper cells, which are characterized by the secretion 
of the effector cytokine IL-17. TH17 cells have critical functions in host defense 
against bacterial and fungal infections, but also can enhance autoimmune and 
inflammatory diseases (Bettelli et al., 2007). For example, patients with 
inflammatory bowl disease (IBD) display increases in TH17 cells and related 
cytokines in affected parts of the intestine (Maloy and Powrie, 2011; 
Schmechel et al., 2008).  Moreover, together with IL-22 (also secreted by 
TH17 cells) IL-17 affects the production of antimicrobial peptides (AMPs) by 
Paneth cells (Ivanov et al., 2009). Germ-free mice show reduced levels of 
TH17 cells in the LP but their numbers are restored after colonization with a 
complex microbiota (Ivanov et al., 2008). Specifically, a particular commensal, 
segmented filamentous bacteria (SFB), strongly induces TH17 cells, which in 
turn recognize SFB antigens through their T cell receptor (TCR) (Goto et al., 
2014b). However, SFB antigens cannot induce TH17 cell differentiation by 
itself but is rather induced through physical interaction of SFB adhering to 
epithelial cells (Atarashi et al., 2015). Moreover, SFB adhesion elicits a 
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distinct gene expression program in epithelial cells such as upregulation of 
serum amyloid A, which supports T cell differentiation together with IL-22 
(produced by ILC3) (Sano et al., 2015).  
Besides the influence of the gut microbiota on pro-inflammatory TH17 cells, 
several studies dissected how intestinal members affect the functional 
development of intestinal FoxP3+ Treg cells. Treg cells exert an 
immunosuppressive effect by preventing effector T cell induction and 
proliferation (Harrison and Powrie, 2013). The intestine harbors different types 
of Treg cells: thymus-derived Treg cells (tTreg) and peripherally derived Treg cells 
(pTreg). Whereas tTreg cells migrate in the intestine and endure functional 
maturation, pTreg cell differentiation occurs in the intestine of uncommitted 
naïve CD4+ T cells (Shevach and Thornton, 2014). pTreg cells are mainly 
found in colonic LP and express the retinoic acid receptor (RAR)-related 
orphan receptor γt (RORγt), whereas tTreg cells can be distinguished by its 
expression of globin transcription factor (GATA) 3 (Tanoue et al., 2016). 
Microbial antigens together with TCR signaling initiate Treg differentiation, 
which is important to inhibit aberrant immune responses to self as well as 
environmental signals and is therefore, pivotal for intestinal homeostasis 
(Sefik et al., 2015; Yang et al., 2016). Especially, IL-10 derived from Treg cells, 
the main producers of IL-10, suppresses the functionality of TH17 cells (Huber 
et al., 2011; Rubtsov et al., 2008). Recent studies shed light on how specific 
bacteria and bacterial derived molecules impact the differentiation and 
expansion of Treg cells. For example Clostridia of the clusters IV, XIVa and 
XVIII contribute to accumulation of colonic Treg cells, in particular those which 
express RORγt, likely through the production of SCFA from dietary fiber 
(Atarashi et al., 2013; 2011; Sefik et al., 2015). In another study, 
Faecalibacterium prausnitzii, a Clostridium specie in the human gut, has been 
reported to greatly induces IL-10 producing T cells (CD4 and CD8αα cells) 
and is less abundant in patients with IBD (Sarrabayrouse et al., 2014). 
Besides bacteria of the class Clostridia, also several bacteria of the class 
Bacteroidetes, especially of the genus Bacteroides (e.g. B. fragilis and B. 
thetaiotamicron) have been demonstrated to affect the induction of intestinal 
pTreg cells (Faith et al., 2014; Round and Mazmanian, 2010).  
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Secretory IgA is constantly produced and binds to intestinal bacteria and 
dietary antigens; therefore, strongly contributes to intestinal homeostasis 
(Mantis et al., 2011). IgA production is highly dependent on the gut 
microbiota. Germ-free mice display reduced levels of IgA expressing cells, 
which is reversed after colonization with gut bacteria (Hapfelmeier et al., 
2010; Peterson et al., 2007). In addition, the complexity of the gut microbiota 
is highly dependent on the diversity of IgA expressing cells (Lindner et al., 
2015).  
 
Taken together, the intestinal microbiota contributes to the functioning of 
innate immune cells, but also to the development and maturation of the 
adaptive immune system (Figure 1.3). In the last years, studies have started 
to uncover how specific members affect distinct cells of the adaptive immune 
system, including TH17, Treg and B cells. However, for most of the commensal 
	   Intes&nal	bacteria	confer	immune-mediated	and	direct	 	 		
								coloniza&on	resistance	against	pathogens		
pTreg Naïve T cell 
Intestinal  
lumen 
Lamina  
propia 
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Butyrate  
Dietary fiber  
IL-17 
DC 
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TH17 Naïve T cell 
IL-10 
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Figure 1.3 - Interactions of commensal bacteria with the mucosal immune system. 
Intestinal bacteria have a large effect on mucosal immune cells. For example, Bacteroides 
fragilis produces PSA, which in turn promotes the induction of mucosal pTreg cells. In addition, 
species of the class Clostridia contribute also to pTreg cell induction via production of butyrate 
from dietary fibre. pTreg cell are an important source of IL-10 controlling intestinal 
homeostasis. In contrast, SFB promote the development of TH17 cells via the production of 
SAA. Moreover, microbiota-derived butyrate is used as energy source by epithelial cells, 
which in turn, contribute to epithelial barrier function through HIF. DC – dendritic cell, HIF - 
hypoxia-inducible factor, IL – interleukin, PSA – polysaccharide A, pTreg – peripherally-derived 
regulatory T cell, SAA – serum amyloid A, TH – T helper cell, tTreg – thymus-derived regulatory 
T cell  
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gut bacteria it is still unknown how they interact with the mucosal adaptive 
immune system, likely even also inducing other adaptive immune signaling 
pathways as shown above.  
 
1.2 The mucosal immune system control the microbiota 
composition 
 
Not only the microbiota contributes to the functionality of the mucosal immune 
system, but also innate and adaptive immune pathways have a great effect on 
the microbial composition in the intestine.  
PRRs have an important role in shaping the composition of the gut microbiota 
and contribute to intestinal homeostasis. Especially in the last years, the 
impact of PRR signaling on the microbiota was manifested through studies of 
inflammatory bowel disease, which is characterized by an overactive immune 
system and diminished epithelial barrier function. Polymorphisms in 
nucleotide-binding oligomerization domain-containing protein 2 (NOD2), a 
well-studied member of the NLR family, is associated with increased 
susceptibly to Crohn’s disease (Heresbach et al., 2004). NOD2 recognizes 
gram-positive and gram-negative bacteria via muramyl dipeptide, constituent 
of bacterial cell walls. In turn, NOD2 regulates via activation of Rip2 and NFκB 
the expression of α-defensins by Paneth cells and therefore controls the 
commensal bacterial microbiota (Lala et al., 2003; Wehkamp et al., 2004). 
Mice deficient in NOD2 shows an aberrant bacterial community in the terminal 
ileum characterized by a higher abundance of Bacteroides spp. and 
Firmicutes spp. compared to wild type mice (Petnicki-Ocwieja et al., 2009). 
Another study showed that NOD2 prevents the growth of the commensal gut 
bacterium Bacteroides vulgatus and therefore, controlling intestinal 
inflammation (Ramanan et al., 2014). Strikingly, two other studies could not 
reveal any differences in the microbial composition of NOD2-deficient mice 
and wild type mice (Robertson et al., 2013; Shanahan et al., 2014).  
Deficiency in the NLR family pyrin domain containing 6 (NLRP6), mainly 
expressed in intestinal epithelial cells, leads to alterations of the microbiota 
composition as well as their function and therefore, increased susceptibility to 
enteric infections (Elinav et al., 2011; Levy et al., 2015; Wlodarska et al., 
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2014). Signaling via myeloid differentiation primary response gene 88 
(MyD88), an adaptor protein in TLR signaling, results in enhanced production 
of AMPs by Paneth cells such as RegIIIγ, a C-type lectin that targets Gram-
positive bacteria (Brandl et al., 2007; Frantz et al., 2012). In addition, MyD88 
signaling regulates mucin production and therefore, maintaining epithelial 
barrier function (Bhinder et al., 2014). Loss of MyD88 in epithelial cells 
enables translocation of opportunistic pathogens such as Klebsiella 
pneumonia (member of the resident gut microbiota) to draining lymph nodes 
(Frantz et al., 2012). Moreover, loss of MyD88 leads to decreased bacterial 
abundances of the phylum Bacteroidetes and increased bacterial numbers of 
the phylum Proteobacteria (Frantz et al., 2012). 
In addition, mice deficient in TLR5, a bacterial flagellin receptor, show 
changes in the composition of the gut microbiota, which was associated with 
the development of metabolic syndrome including hypertension, insulin 
resistance and increased adiposity (Vijay-Kumar et al., 2010). Furthermore, 
transferring gut bacteria of TLR5-deficient mice to wild type germ-free mice 
has been reported to result in a similar metabolic syndrome as observed in 
Tlr5-/- mice (Vijay-Kumar et al., 2010). TLR5-deficient mice also revealed 
reduced levels of flagellin-specific IgA, which leads to an upregulated 
expression of flagella-related genes by several commensal bacteria 
(Cullender et al., 2013). Similar to what was observed in NOD2 deficient mice, 
some research groups could not observe alteration in the microbiota in TLR5 
knockout mice as seen in the study of Vijay-Kumar et al. (Vijay-Kumar et al., 
2010).  
Moreover, the mucosal adaptive immune system also contributes to the 
composition of the microbiota. Humans carrying selective IgA deficiency 
display a greater abundance of E. coli with potentially inflammatogenic 
properties, which may contribute to the development of gastrointestinal 
diseases (Friman et al., 2002).  
The mucosal host immune system controls the intestinal microbiota via 
activation of specific innate and adaptive immune responses providing 
intestinal homeostasis. Defects in the immune system potentially lead to a 
disrupted intestinal homeostasis and therefore, intestinal dysbiosis, which 
increases the risk for gastrointestinal diseases and metabolic dysfunctions. As 
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discussed for NOD2 and TLR5 deficiencies, there is still a debate in the 
research field which parts of the mucosal immune system regulate the 
composition of the microbiota. Most of the studies were performed using 
conventionally raised mouse lines from different vendors, which differ in their 
microbial composition (Ericsson et al., 2015). Therefore, it is likely that the 
effect of signaling immune pathways depends also on the resident microbiota 
composition.  
In summary, the interplay between the host and the microbiota drives 
intestinal homeostasis. Commensal intestinal bacteria have a profound effect 
on the mucosal immune system, whereas mucosal immune signaling impacts 
the function as well the composition of the microbiota. Alterations in the 
composition of the microbiota can lead to profound consequences for the 
host’s physiology, as reported in IBD patients and obesity (Bervoets et al., 
2013; Hold et al., 2014).  Only a few bacteria are already identified, which 
regulate inflammatory responses, contributing to host’s health and more 
research is needed in this field. Moreover, a more profound knowledge how 
bacteria influence the mucosal immune system and contributing to a balanced 
homeostasis in the gut is crucial to treat microbiota-associated diseases.  
 
1.3 Gastrointestinal infections 
 
Gastrointestinal infections result in inflammation of the gastrointestinal tract 
causing symptoms such as diarrhea and abdominal pain that lead to death in 
severe cases. Gastrointestinal infections are transmitted by contaminated 
food and water as well as contact with infected persons as a result of poor 
hygiene. According to the World Health Organization, every year 1.7 billion 
cases of diarrheal disease occur, causing nearly 1.5 million deaths (second 
leading cause of death in children >5 years old) (WHO, 2013).  
A wide range of pathogens, including viruses, bacteria, parasites and fungus, 
causes gastrointestinal infections. Norovirus, Campylobacter spp., 
nontyphoidal Salmonella spp. and pathogenic Escherichia coli (shiga toxin-
producing E.coli) are responsible for the majority of gastroenteritis infection 
worldwide and are mainly spread by contaminated food (Fletcher et al., 2013). 
Every year approximately 11.000 cases of Salmonellosis (caused by 
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Salmonella spp.) are identified (RKI, 2016). Moreover, in 2011, Germany 
suffered from one of the largest outbreaks of a food-born infection; caused by 
enterohaemorrhagic Escherichia coli (EHEC), a shiga-toxin producing E.coli 
with the serotype O104:H4. Approximately 4.000 patients with EHEC were 
observed, resulting in 54 deaths (Frank et al., 2011). About 20% of the 
patients developed a haemolytic uraemic syndrome (HUS), which is 
characterized by thrombocytopenia (low amount of platelets), 
microangiopathic hemolytic anemia and kidney failure (Frank et al., 2011).  
The development of multiple antibiotic resistances in enteric pathogens is an 
increasingly global risk problem, in particular in health care units. Therefore, 
antibiotic resistances threaten the ability to treat common infectious enteric 
disease. Over the years, the inappropriate antibiotic overuse in humans and 
animals accelerated the development of multiple antibiotic resistances in 
bacteria. Moreover, multidrug resistant bacteria can spread easily via the food 
chain or through the environment (e.g. water and soil) to humans. However, 
the use of antibiotics is still needed, since it is the most effective treatment 
against pathogens in human and animals. Therefore, new therapies are 
needed to combat enteric pathogens, especially for those who acquired 
antimicrobial resistances and subsequently antibiotic treatment normally fails. 
For example, exchanging the microbiota of diseased patients by stool 
transplantation from healthy persons was reported to eradicate antibiotic-
resistant pathogens (Millan et al., 2016). Thus, it is important to understand in 
detail, how pathogens interact with the host exploiting their virulence factors 
for colonization and which specific role the microbiota has to confer resistance 
to enteric infections. In the next part, I will focus on two enteric pathogens, 
Salmonella enterica serovar Typhimurium and Citrobacter rodentium, which 
are both used in this thesis to identify microbial signatures associated with 
lower disease severtiy (Chapter 2 and 3). Moreover, I will explain how 
commensal bacteria combat enteric infections. 
 
1.4.1 Salmonella enterica ssp. enterica serovar Typhimurium 
 
Salmonella spp. are a group of gram-negative food-borne pathogens 
belonging to the bacterial family of Enterobacteriaceae. The group of 
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Salmonella comprises two species (S. enterica and S. bongori) and six 
subspecies, including more than 2500 serovars (Coburn et al., 2007). S. 
enterica can infect a broad range of species causing gastroenteritis and 
typhoid fever, depending on the serovars.  For example, S. Typhi disseminate 
systemically by spreading throughout the peripheral lymphatic system, 
causing typhoid fever (Everest et al., 2001). In contrast, most of the serovars 
of S. enterica cause nontyphoidal symptoms, triggering rapid inflammatory 
responses, causing an estimated 93.8 million cases worldwide per year 
(Majowicz et al., 2010). 
In contrast to S. Typhi, the nontyphoidal Salmonella enterica serovar 
Typhimurium can not only infect humans but also induce gastroenteritis in 
other mammalians. Therefore, S. Typhimurium is also used in mouse models 
to study immune responses to Salmonella and bacterial virulence factors. In 
mice, S. Typhimurium can colonize the gastrointestinal tract and triggering a 
strong gut inflammation, but can also spread via the GALT to colonizes 
systemic sites (Carter and Collins, 1974). Infection with S. Typhimurium in 
normal laboratory mice results in a poor luminal colonization. S. Typhimurium 
disseminate in systemic organs similar to what is known in human typhoid 
diseases (e.g. infection with S. typhi) and therefore, is used as a mouse 
model to study human typhoidal Salmonella infections (Tsolis et al., 1999). In 
contrast, antibiotic treatment in mice before S. Typhimurium infection results 
in strong gastroenteritis, showing similar characteristics as seen in human 
nontyphoidal infections. Therefore, the antibiotic-induced (e.g. streptomycin) 
S. Typhimurium model is a well-established mouse model to study 
Salmonella-induced gastrointestinal inflammation (Barthel et al., 2003).  
S. Typhimurium elicits mucosal inflammation by utilizing virulence factors and 
triggering inflammation by PRRs. To invade the tissue and to cause 
gastroenteritis, first S. Typhimurium closely binds to enterocytes by 
expression of adhesins and its flagellin (Bäumler et al., 1996; Stecher et al., 
2008). S. Typhimurium elicits mainly gut inflammation via two type III 
secretion systems (T3SS), T3SS-1 and T3SS-2, which are encoded in the 
Salmonella pathogenicity island (SPI)-1 and SPI-2, respectively.  Both T3SSs 
trigger inflammation independently of each other. T3SS-1 induces 
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inflammation within the first 6-10 hours post infection (p.i.) and T3SS-2 
triggers enteropathy at 3 days p.i. (Kaiser et al., 2012).  
Via the T3SS-1, S. Typhimurium delivers effector proteins such as SipA and 
SopE into the host cell, promoting pathogen entry into epithelial cells and 
triggering different pro-inflammation responses (Müller et al., 2009; Wall et al., 
2007). For instance, SipA facilitates bacterial invasion by binding to actin and 
inhibiting actin depolymerization (Zhou et al., 1999). SipA also induce the 
activation of epithelial pathways leading to neutrophil migration (Lee et al., 
2000). It has been shown that SipA mediates NOD1/NOD2 signaling that 
activates NF-κB-dependent inflammatory responses (Keestra et al., 2011). 
Moreover, NOD1/NOD2 signaling was identified to trigger early IL-17 
production (Geddes et al., 2011).  
SopE, a guanine nucleotide exchange factor, activates host cellular Rho 
GTPases.  For example the two Rho GTPases Rac1 and Cdc42 support 
cytoskeletal rearrangement and therefore, help to engulf Salmonella (Hardt et 
al., 1998). Activation of Rac1 and Cdc42 induce also NOD1 signaling and 
consequently, activates RIP2-NF-κB-dependent host inflammatory responses 
(Keestra et al., 2013). Moreover, SopE supports caspase-1 activation and 
their cytokines IL-1β and IL-18 to trigger mucosal inflammation (Müller et al., 
2009).  
In contrast to T3SS-1, T3SS-2 is activated after Salmonella host cell entry. 
Colonization of the LP via the T3SS-2-dependent pathway (in absence of 
T3SS-1) is mediated by CD11c+CX3CR1+ monocytic phagocytes 
(Hapfelmeier et al., 2008). T3SS-2 enables Salmonella to persist and replicate 
within a cellular vacuolar department of macrophages and dendritic cells. In 
turn, different PRRs are activated such as TLRs to mediate inflammatory 
responses. For instance, TLR2 and TLR4 and their downstream adaptor 
molecule Myd88 are pivotal for host defense against Salmonella infection 
(Weiss et al., 2004).  
As discussed above, upon infection and stimulation of different PRRs, innate 
and adapted mucosal immune responses are initiated (Figure 1.4). The 
induction of inflammatory cytokines, including IL-1β, IL-18 and IL-6, help the 
host to combat infection. Another important induced cytokine is interferon 
(IFN)γ, which is mainly produced by natural killer cells (NK) and T cells, 
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supporting lowering pathogen loads in the mucosal tissue (Kupz et al., 2013; 
Srinivasan et al., 2004).  
Besides the inflammatory response of the host to constrain Salmonella 
infection, also the host microbiota is an important factor to control pathogen 
loads. In conventionally raised mice, S. Typhimurium establishes a poor 
luminal colonization (Barthel et al., 2003). This phenomenon is referred to as 
colonization resistance, which explains interactions of the microbiota with the 
pathogen and host to protect against invading pathogens (van der Waaij et 
al., 1971). Germ-free mice and antibiotic treatment prior S. Typhimurium 
infection in mice (e.g. treatment with a single dose of streptomycin, ampicillin 
or vancomycin) leads to high pathogen colonization in the lumen and gut 
tissue, resulting in severe intestinal inflammation already after early time 
points of infection (Barthel et al., 2003; Stecher et al., 2005). Therefore, the 
microbiota has a large effect on disease progression and disruption of the 
microbiota enhances disease susceptibility.  
	   Routes	of	Salmonella	to	invade	the	intes2nal	mucosa		
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Figure 1.4 – Salmonella invasion and host immune response. Salmonella invades the 
host via different routes. (1) Salmonella invade enterocytes through the injection of effector 
proteins, which is mediated by SPI-1 Type 3 secretion system. (2) M cells transport 
Salmonella to the lamina propria by transcytosis. (3) CX3CR1+ DCs take up Salmonella 
with their transepithelial dendrites. After detection of Salmonella by PRRs, an immune 
response is initiated, which leads to production of pro-inflammatory cytokines (e.g. IL-6, IL-
1β). In turn, adaptive immune cells are activated, targeting intra- and extracellular 
Salmonella. Influx of neutrophils leads not only to killing of pathogens, but also damage 
epithelium, causing loss of epithelial barrier function. IFN – interferone, IL – interleukin, M 
cell – microfold cell, MΘ – macrophages, NK cell – natural killer cell, Spi - Salmonella 
pathogenicity island, tiDC – tissue residing dendritic cell, TNF – tumor necrosis factor  
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However, Salmonella also developed mechanisms to exploit the microbiota 
and host mucosal defense for its own outgrowth and colonization. For 
instance, during inflammation the host produces large amounts of lipocalin-2, 
which sequester the siderophore enterochelin in the gut lumen. Siderophores 
are needed for the efficient uptake of iron. For example, E. coli produces 
enterochelin that is pivotal to import iron via the fep ABC transporter 
(Buchanan et al., 1999). In case of S. Typhimurium, it produces salmochelin, 
which is not bound by lipocalin-2 and therefore, Salmonella can still use iron 
during gut inflammation giving it a growth advantage towards commensal 
bacteria as E. coli.  
To summarize, S. Typhimurium uses its virulence factors to cross the 
epithelial barrier colonizing the LP and to persist in host immune cells. On the 
other side, the host activates the innate and adaptive mucosal immune 
system to combat against infection. Intriguingly, S. Typhimurium also benefits 
from the host inflammatory response. However, it has been shown that the 
community of intestinal commensal bacteria greatly influences disease 
progression. But which specific members of the microbiota affect Salmonella 
colonization are still not completely identified. Moreover, is not clear yet, how 
these specific members interact with Salmonella or the host to prevent 
pathogen colonization.  
 
1.4.2 Citrobacter rodentium 
 
Citrobacter rodentium is a mouse-restricted pathogen, which is used as model 
for the human pathogens enterohemorrhagic Escherichia coli (EHEC) and 
enteropathogenic E.coli (EPEC). Similar to EHEC and EPEC in humans, C. 
rodentium is a highly infectious pathogen causing colitis and colonic 
hyperplasia in mice (Luperchio et al., 2000).  C. rodentium is a member of the 
family Enterobacteriaceae and genetically related to EPEC and EHEC, 
sharing about 67% of their genes, including important homolog virulence 
factors (Luperchio et al., 2000; Petty et al., 2010). Moreover, C. rodentium is 
transmitted by the fecal-oral route and colonize the gut mucosa by formation 
of attaching/effacing (A/E) lesions on enterocytes, which are indistinguishable 
from those triggered by EPEC and EHEC (Schauer and Falkow, 1993). A/E 
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lesions are formed by attachment to intestinal epithelial cells, effacement of 
the brush border villi and formation pedestal-like extensions of the epithelial 
cells beneath the adherent bacteria (Schauer and Falkow, 1993). To induce 
A/E lesions, C. rodentium expresses the adhesion molecule intimin, T3SS and 
effector proteins, which are encoded on the locus of enterocyte effacement 
(LEE) pathogenicity island, also shared by the pathogens EPEC and EHEC 
(Deng et al., 2001). In the host cell translocated effector proteins (e.g. Tir, 
Esp, Nls) trigger signal transduction and actin polymerization, which is 
important to form A/E lesions (Deng et al., 2003; Kelly et al., 2006; Mundy et 
al., 2004). In addition to the T3SS, C. rodentium also express a type IV pilus, 
which is important for colonization possibly due to its role in adherence of 
epithelial cells as well as two type VI secretion systems (CTS1 and CTS2), 
which may contribute to colonization resistance by outcompeting intestinal 
bacteria (Gueguen and Cascales, 2013; Mundy et al., 2003; Petty et al., 
2010).  
C. rodentium induces a variety of host defense mechanisms upon being 
recognized by different PRRs. For instance, deficiency in Myd88 leads to 
increased colitis and higher luminal bacterial numbers (Gibson et al., 2008). 
Moreover, several NLRs have been identified to be activated upon C. 
rodentium colonization and helping the host to combat the infection. 
Intracellular NOD2 sensor regulated clearance of C. rodentium by CCL2-
dependent recruitment of inflammatory monocytes and IL-12 production (Kim 
et al., 2011). Additionally, mice lacking components of the NLRP3-Caspase-1-
IL-1β pathway results in higher bacteria burden, indicating that this pro-
inflammatory axis is critical for host defense against C. rodentium (Liu et al., 
2012). As already mentioned before, activation of PRRs increases the 
production of pro-inflammatory cytokines to combat C. rodentium infections. 
Besides the aforementioned cytokines IL-22, IL-1β and IL-18, production of 
IL-17 during infection plays a crucial role in intestinal pathology. Early IL-17 
production of CD4+ T cells was dependent on NOD1 and NOD2 sensors, 
controlling mucosal immunity against C. rodentium (Geddes et al., 2011; 
Torchinsky et al., 2009).  
Similar as discussed in S. Typhimurium infections, the microbiota has a great 
impact to control C. rodentium colonization and disease progression. It has 
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been demonstrated, that germ-free mice showed a higher luminal pathogen 
load (Kamada et al., 2012). The same study showed that the microbiota is 
needed for eradication of C. rodentium (Kamada et al., 2012). Moreover, 
alteration of the microbiota composition due to antibiotic treatment (e.g. with 
metronidazole) increases C. rodentium colonization (Wlodarska et al., 2011). 
These studies indicated the importance of the microbiota for disease 
pathogenicity.  
Altogether, C. rodentium is a good model to study A/E pathogens including 
their colonization and virulence mechanisms as well as the activation of innate 
and adaptive mucosal immune pathways. However, the microbiota has been 
described to affect different parts of the disease progression. But how single 
bacteria of the gut microbiota can influence disease outcome is completely 
not understood.  
 
1.4 Impact of the microbiota on pathogen colonization 
 
In the gastrointestinal tract, commensal bacteria are crucial for protecting the 
host against invading pathogens. To confer resistance, commensal bacteria 
developed different mechanisms to inhibit harmful pathogens. Nevertheless, 
commensal bacteria and pathogen share the same environment such as 
nutrients and niches. Therefore, the pathogen also evolved mechanisms to 
exploit microbiota-derived products.  
 
 
1.5.1 Microbiota-mediated colonization resistance  
 
One of the most important functions of the microbiota is to support resistance 
to colonization of exogenous pathogens in a process referred to as 
colonization resistance. Already five decades ago, Bohnhoff and Miller 
identified that mice exhibit a higher susceptibility to S. Typhimurium when 
treated with antibiotics and pointed out the clinical problem of infections in 
patients undergoing antibiotic treatment (Bohnhoff and Miller, 1962). Since 
then other researcher also highlighted the importance of the gut microbiota by 
demonstrating that germ-free mice as well as antibiotic treated mice with an 
altered microbiota composition and reduced diversity display a higher 
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susceptibility to several enteric pathogens (Bohnhoff and Miller, 1962; 
Kamada et al., 2012; Ng et al., 2014; Sprinz et al., 1961).  
Researchers could identify several mechanisms how commensal bacteria 
combat against pathogen colonization. The gut microbiota confers pathogen 
colonization resistance via different ways of defense mechanisms: direct 
inhibition, activation of the immune system and maintenance of the epithelial 
barrier (McKenney and Pamer, 2015) (Figure 1.5). 
Intestinal bacteria affect pathogen growth by competing for nutrients or by 
activating inhibitory molecules. For instance, bacteria can produce AMP such 
as bacterocin. Lactobacillus lactis produces the bacterocin nisin, which was 
shown to target the growth of C. difficile (Le Lay et al., 2016). Also the two-
component bacterocin thuricin CD produced by Bacillus thuringiensis shows 
activity against C. difficile (Rea et al., 2010). Moreover, secondary bile acids, 
which are generated by commensal bacteria from primary bile acids have 
been shown to inhibit the growth of C. difficile (Buffie et al., 2015). In addition, 
the consumption of specific nutrients by commensal bacteria contributes to 
competitive exclusion of the pathogen by limiting nutrients availability. For 
instance, commensal E. coli strains inhibit growth of pathogenic E. coli 
because of similar nutrient utilization (Leatham et al., 2009). B. 
thetaiotaomicron has the ability to inhibit C. rodentium infection by consuming 
structurally similar carbohydrates (Kamada et al., 2012).  
In contrast to direct mechanisms, indirect ones require microbiota dependent 
activation of the immune system, which in turn, targets pathogen colonization 
by e.g. the production of AMPs. Polysaccharide A (PSA) from the capsule of 
the human commensal Bacteroides fragilis induces the conversion of CD4+ T 
cells into Foxp3+ Treg cells, which in turn, enhances the IL-10 production 
protecting mice from Helicobacter hepaticus induced colitis (Round and 
Mazmanian, 2010). The mouse commensal bacteria SFB mediates TH17 
activation resulting in IL-22 and IL-17 production, which induces the release of 
AMPs targeting C. rodentium (Goto et al., 2014b; Ivanov et al., 2009; Yang et 
al., 2014). Also commensal bacteria influence S. Typhimurium infection. It 
was shown that gut bacteria activate Myd88- and NOD2-dependent pathways 
to express several AMPs, which inhibit colonization of S. Typhimurium (Ayabe 
et al., 2000; Vaishnava et al., 2008).  
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The gut microbiota contributes also to maintenance of the intestinal barrier, 
which influences strongly the tissue colonization of pathogenic bacteria. Mucin 
is produced and secreted by goblet cells, which are simple columnar epithelial 
cells, scattered among the gastrointestinal tract. Gut bacteria are crucial for 
proper mucus development. Germ-free mice display a thinner mucus layer 
and by bacteria more penetrable, which is reverted by restoring a normal 
microbiota (Johansson et al., 2015). Moreover, the bacterial outer membrane 
component lipopolysaccharides (LPS) promotes the thickness of the mucus 
layer (Petersson et al., 2011). Antibiotic treatment disrupts the mucosal barrier 
supporting bacterial invasion (Wlodarska et al., 2011).  
 
 
 
 
 
 
 
 
 
 
 
 
Moreover, the enzyme 2-α-L-fucosyltransferase 2 (FUT2) adds fucose 
residues to intestinal mucins (Hurd et al., 2005). Fucose is used as substrate 
of commensal intestinal bacteria supporting the bacterial diversity and in turn, 
decrease pathogen invasion (Pickard et al., 2014). The mucus fucosylation 
Mucus Paneth 
cells
TH17 
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IL-17
Antimicrobial 
peptides 
SFB
IL-22
CD11c+
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SAA
C. rodentium
IL-22
ILC3
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LPS
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L. lactis
Inhibitory  
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Direct  Epithelial barrier   Immune-mediated
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Figure 1.5 - Mechanisms of colonization resistance. Commensal bacteria support the 
host against invading pathogens through different mechanisms. For example, direct 
mechanisms include the competing for nutrients, inhibiting pathogen growth. In addition, 
commensal bacteria increase epithelial barrier function. For example, production of IL-22 
induced by commensal bacteria leads to induction of Fut2 expression, contriburing to 
bacterial diversity, which decreases pathogen colonization. Furthermore, commensal 
bacteria confer resistance by activating the immune system, which in turn target the 
pathogen. For example, SFB enhances antimicrobial peptide expression, inhibiting 
Citrobacter rodentium growth. DC – dendritic cell, Fut2 – Fucosyltransferase 2, IL-
interleukin, ILC – Innate lymphoid cells, LPS – Lipopolysaccharides, SFB – Segmented 
filamentous bacteria, SAA – Serum amyloid A, TH – T helper cell (Adapted from Thiemann 
et al., 2016) 
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status is microbiota-dependent via the induction of IL-22 by type 3 innate 
lymphoid cells (ILCs) (Goto et al., 2014a). Mice deficient in Fut2 show a 
higher bacterial burden of S. Typhimurium and C. rodentium (Goto et al., 
2014a; Pickard et al., 2014). Moreover, administration of fucosylated 
molecules to C. rodentium infected Il22ra1-/- mice helps to restore diversity of 
the gut community, which influences enteric infection (Pham et al., 2014). 
Altogether, microbiota-dependent host protection is mediated by direct 
mechanisms, immune system induced indirect pathways and by the 
maintenance of the epithelial barrier. However, the microbiota harbors a 
diverse community of bacteria, which protect the host via different, specific 
mechanisms. Until now, researches could identify only a few mechanisms 
how single bacteria can limit pathogen colonization. Finding new mechanisms 
are crucial to develop mucosal therapies to combat against gastrointestinal 
diseases.  
 
1.5.2 Pathogen exploitation of the microbiota  
 
The microbiota protect the host for pathogen colonization. To overcome the 
microbiota, the pathogen evolved mechanisms to invade the host by 
exploiting the microbiota. The gastrointestinal tract contains a taxonomical 
diverse bacterial ecosystem, generating a wide variety of metabolites. Enteric 
pathogens use those microbiota-derived products such as sugars, organic 
and inorganic compounds as nutrients to colonize and deploy their virulence 
genes.  
Distinct intestinal commensals, mainly members of the phylum Bacteroidetes, 
are able to degrade complex food- and host-derived carbohydrates due to 
their expression of specific hydrolases. These microbiota-liberated sugars are 
an important nutrient source for enteric pathogens, which lack enzymes for 
that degradation. For instance, S. Typhimurium and C. difficile catabolize 
sialic acid, one of the components of the mucus layer. Since both pathogens 
cannot liberate the sugar out of the mucus layer, they require sialidase activity 
of commensal bacteria (Ng et al., 2014). Colonization of germ-free mice with 
the sialidase-deficient intestinal commensal, B. thetaiotaomicron, decreases 
the level of liberated sialic acids, thereby reducing the colonization of C. 
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difficile (Ng et al., 2014). B. thetaiotaomicron not only degrade sialic acid from 
the mucus, it also liberates fucose from host glycans by producing fucosidase. 
In turn, EHEC senses free fucose, which enhances their colonization by 
increasing expression of virulence genes (Pacheco et al., 2012).  
The microbiota produces also distinct by-products, derived from anaerobic 
fermentation, which enteric pathogens can use for growth advantage. One 
example is the microbiota-derived byproduct hydrogen sulfide (H2S). During 
gastrointestinal inflammation, enterocytes transform H2S to tetrathionate, in a 
neutrophil- and reactive oxygen species (ROS)-dependent pathway. In turn, 
S. Typhimurium uses tetrathionate as electron acceptor for anaerobic 
respiration (Winter et al., 2010). Moreover, S. Typhimurium utilize microbiota-
derived hydrogen as an energy source for outgrowth (Maier et al., 2013). 
Another microbiota by-product, succinate, is metabolized as carbon source for 
C. rodentium growth enhancing their virulence genes. Levels of succinate is 
significantly higher in B. thetaiotaomicron reconstituted mice (Curtis et al., 
2014). Besides succinate, also SCFA induce the expression of different 
virulence genes in S. Typhimurium (Spi-1) and EHEC (LEE PAI) (Lawhon et 
al., 2002; Takao et al., 2014).  
In summary, intestinal bacteria provide access to different sugars, electron 
acceptors, organic and inorganic compounds, which enteric pathogens exploit 
as nutrient source or to increase virulence signals. However, the 
gastrointestinal tract harbors a great diversity of commensal bacteria, forming 
a complex metabolic network, which is still challenging to study. Therefore, 
many pathways, how pathogens exploit the microbiota for their advantage, 
are still not identified. 
 
1.5 Tools for analyzing the gut microbiota 
 
Studying the composition and the functionality of the microbiota is still 
challenging. Different “omics” approaches, including culture-dependent and 
culture-independent technologies, are needed to study the composition of the 
microbiota as well as the interaction with the host, the pathogen and other 
commensal bacteria.  
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Until 10 years ago, the characterization of the gut microbiome was driven by 
culture-based techniques and research was focused on bacteria, which were 
culturable. But, due to the complex gut ecosystem and its tight regulated 
interplay between intestinal bacteria and the immune system, numerous 
intestinal bacteria are difficult to culture. Therefore, culture-based techniques 
do not represent the whole gut microbiota (Browne et al., 2016; Rappé and 
Giovannoni, 2003). Hence, culture-independent, DNA-based next-generation 
sequencing technologies (NGS) offered new opportunities to study the 
complex ecosystem of the microbiota in the last decade. Both, targeted 
sequencing as well as whole-genome sequencing technologies are used to 
study bacterial communities. 
Sequencing of targeted marker genes provides a rapid, cost-efficient and 
precise approach to investigate the diversity and composition of a microbial 
community. The 16S ribosomal RNA (16S rRNA) gene is the most frequently 
targeted marker gene and is used for standard identification of microbes due 
to its ubiquitous presence in prokaryotes. The 16S rRNA gene belongs to the 
prokaryotic ribosome and contain highly conserved as well as hyper variable 
regions (V1-V9). Therefore, the 16S rRNA gene provides species-specific 
signatures, which allows distinguishing different taxa. Moreover, 16S rRNA-
based techniques permit to identify uncultivable bacteria.  
Highly conserved 16S rRNA regions (slow evolving regions) are used to 
design PCR primers, which amplify also the highly variable 16S rRNA regions 
(Kuczynski et al., 2011). The design of those PCR primers is critical for 
taxonomic coverage and specificity of amplified bacterial sequences, 
depending on the host species (e.g. mouse, human) and the target bacteria. 
For instance, targeting the variable region V1-V2 results in under 
representative taxa as Bifidobacterium and Verrucomicrobia (Bergmann et al., 
2011; Hayashi et al., 2004), whereas V1-V2 best differentiate among 
Staphylococcus species (Chakravorty et al., 2007). Currently, the variable 
regions V1-V2 or V4 are most commonly used to study the gut microbiota.  
However, 16S rRNA studies do not allow gaining insights into microbial 
functionality, because only a small fragment of the whole genome is analyzed. 
Furthermore, annotation of bacteria is based on OTUs with 97% similarity, 
providing data, which are less accurate at bacterial species and strain level. 
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Characterizing whole bacterial genomes by metagenomic studies is used to 
describe the functional potential of represented bacteria. Different than 16S 
rRNA sequencing, metagenomic approaches such as whole genome shotgun 
(WGS) sequencing have the advantage to not only targeting a specific gene. 
Therefore, bacteria can be more precisely determined at species level, if a 
good database is available (Ranjan et al., 2016). Nevertheless, metagenomic 
studies have a lower resolution of the present bacteria in the analyzed 
community as 16S rRNA sequencing (Kuczynski et al., 2011). In addition, 
compared to 16S rRNA sequencing, metagenomic studies are also a more 
expensive approach. Moreover, a more complex data analysis is needed.  
However, by using DNA based methods such as 16S rRNA sequencing and 
metagenomic of DNA samples, vitality of bacteria is not assessed. Therefore, 
RNA-based studies by sequencing 16S rRNA transcripts or whole 
transcriptomes (metatranscriptomic studies) provide insights into the viable 
community. Moreover, to couple these data with metaproteomics and 
metabolomics studies is essential to understand the metabolic activity and 
therefore functionality of the bacteria in the intestine.  
In the last years, especially Illumina-based sequencing platform were used 
more frequently in laboratories due to its high number of reads and low cost 
(Weinstock, 2012). Illumina sequencing is based on the incorporation of 
fluorescently labeled deoxyribonucleotide triphosphates (dNTPs) into a 
synthesizing DNA template strand. Before DNA sequencing, 5’ and 3’ strand 
adapters are added to the target gene, which binds in an Illumina flow cell to 
surface-bound oligos complementary to the adapters and is amplified in clonal 
clusters through bridge amplification. During DNA synthesis, incorporated 
nucleotides are identified by fluorophore excitation. Therefore, millions of 
fragments can be sequenced simultaneously. To process a large number of 
samples, multiplexing of samples is a useful technique that is accomplished 
due to adding 5’ and 3’ strand barcode sequences by PCR to distinguish 
several samples after sequencing. Following sequencing of the target gene, 
these millions of generated reads needs to be aligned and clustered based on 
their similarity into operational taxonomic units (OTUs) to assign the DNA 
sequences to bacterial species. Reads are normally clustered together, which 
have a 97% similarity.  
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Culture-independent DNA and RNA-based sequencing technologies are an 
essential tool to identify microbial communities and provide knowledge about 
bacteria, which are associated to specific health and disease states. However, 
culture-dependent techniques coupled with animal models contribute crucially 
to the urgently need to show causality rather than association and to study 
microbial interactions between the microbiota and the host.  
However, isolation of novel bacterial species is laborious. Most of the 
intestinal bacteria require anaerobic conditions. Moreover, some bacteria 
need for their growth the interaction with other microorganism, e.g. to provide 
essential nutrients. These interactions are often complex and largely 
unknown. In the last years, more attention has been paid to large-scale 
isolations and new culture techniques. Those microbial culturomics data 
include for example the use of different media, temperature, pH and 
atmospheres, which are coupled with MALDI-TOF mass spectrometry (MS) 
studies (Lagier et al., 2012). Data of those studies possibly simplify to set up 
the best conditions to isolate novel bacterial species.  
Moreover, animal models allow verification of correlation studies in a 
controlled experimental setup as well as development of mechanistic and 
functional research on host-microbe interactions. Especially, microbial 
interactions with the host immune system are hard to study in human cohorts. 
Furthermore, our recent insights of the host-microbiota interplay result mainly 
from studies with germ-free mice. Germ-free mice do not harbor any 
microorganisms and are raised in isolators to ensure a microorganism-free 
environment, including bacteria, viruses and eukaryotes (Rooks and Garrett, 
2016). A vast number of wild type mouse strains and knockout strains are 
available in germ-free conditions. With the help of germ-free mice, 
researchers can inoculate specific bacteria or a defined bacterial mix to 
generate a desired microbiota. Those mice are referred to as gnotobiotic 
mice, which also can be further challenged (Rooks and Garrett, 2016). 
Moreover, mice with a defined humanized microbiota can be generated 
(Goodman et al., 2011). In the future, these experiments could be extended to 
mice with a humanized immune system.  
In the last decade, genomic-approaches have greatly advanced our 
understanding about complex microbial ecosystems in a rapid and cost-
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efficient way. However, still many of the intestinal bacteria could not yet be 
isolated. Nevertheless isolation of bacterial species is important to show direct 
causality and is crucial for development of novel bacterial therapeutics in the 
future (Walker et al., 2014) .  
In summary, a combination of culture-independent and –dependent tools is 
required to fully understand the complexity of the microbiota and their 
functionality.  
 
1.6 Strategies to manipulate the gut microbiota 
 
Several diseases are associated with an altered gut microbiota, such as IBD, 
colorectal cancer as well as obesity and diabetes (Carding et al., 2015). 
Moreover, studies have associated lower microbial diversity with increased 
susceptibility to intestinal diseases (Manichanh et al., 2006; Png et al., 2010), 
which might be traced back to the lack of specific beneficial bacteria. 
Therefore, a great interest started to manipulate the microbiota in order to 
confer benefits for host’s health. Currently, transfer of complex communities 
from a healthy donor to a diseased recipient (known as fecal transplantations) 
as well as the use of novel prebiotics and probiotics are investigated by 
researchers; especially, for the urgent need to decrease susceptibility to 
enteric multi-drug resistant infections.  
In the last years, fecal transplantation as therapy gained great success due to 
the amelioration of recurrent C. difficile infection (CDI), possibly due to 
enhancement of diversity and richness of the recipient’s microbiota. For 
instance, CDI was strongly associated with a dysbiotic status of the 
microbiota, mainly after antibiotic treatment (Stevens et al., 2011). Recurrent 
fecal transplantation to patients with recurrent CDI showed efficiency rates of 
about 90% (Landy et al., 2011). Moreover, the still increasing demand for 
fecal transplantations requires the development of frozen stool banks in 
analogy of blood blanks, which simplifies the screening for donor samples 
regarding potential pathogens and recipient’s compatibility (Paramsothy et al., 
2015). In addition, strict criteria regarding donors BMI, blood counts and 
inflammatory markers are crucial for selection of fecal transplantation donors.  
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Nevertheless, fecal transplantation harbors several risk factors. Transferring a 
bulk community could potentially include opportunistic pathogens, which 
potentially poses significant regulatory hurdles. Moreover, it is difficult to 
completely identify the community using NGS based approaches. Even small 
amounts of harmful bacteria possibly could have tremendous long-term 
effects on the recipient’s host. Additionally, bacteria of the fecal transplant 
could possibly change their behavior in the new environment of the recipient 
due to altered host genotype, diet and the residual commensal microbiota. 
Therefore, beneficial commensals could potentially develop to harmful 
bacteria.  
Because fecal transplantation is associated with several risks, the need for 
transferring well-characterized bacterial communities is rising. Different 
studies have already been shown that bacterial mixtures prevent CDI. Already 
15 years ago, in a small-scale study Tvede and Rask-Madsen identified a 
mixture of 10 isolated bacteria, which was effective in patients with CDI 
(Tvede and Rask-Madsen, 1989). More recently, a study with 33 isolated 
bacteria could cure CDI in patients, who had failed at least three courses of 
antibiotic treatment (Petrof et al., 2013). 
Overall, fecal transplantation is a promising therapeutic approach, in particular 
for enteric infections such as CDI. Though, fecal transplantation harbors 
several risks as transfer of inadvertent harmful bacteria. Therefore, identifying 
a mixture of beneficial bacteria or a single bacterium (probiotics) as well as 
the discovery of substances that induce the growth of beneficial bacteria 
(prebiotics) is needed. Until then, fecal transplantation offers a promising 
intermediate treatment.  
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1.7 Aim of the study 
 
The microbiota protects the host against invading pathogens through various 
mechanisms. However, which distinct members of the microbiota decrease 
susceptibility as well as how they protect the host is far from being completely 
understood. The aim of the study is to identify commensal gut bacteria, which 
are associated with decreased susceptibility to gastrointestinal infections. 
Isolating of associated bacteria is important to investigate the causality. 
Moreover, identifying how target bacteria confer colonization resistance (e.g. 
direct mechanisms, immune-mediated indirect pathways or by the 
maintenance of the epithelial barrier) is crucial to understand the important 
interplay between the microbiota and the pathogen. To conduct these studies, 
mice harboring different microbiota compositions are infected with the murine 
gastrointestinal pathogens S. Typhimurium and C. rodentium with the aim to: 
 
1. Finding isogenic mouse lines with distinct microbiota 
compositions, which differ in their disease susceptibility to 
enteric infections: Isogenic mouse lines with different microbiota 
compositions are infected with enteric mouse pathogens S. 
Typhimurium and C. rodentium. Using cohousing and fecal 
transplantation from resistant to susceptible mice help to understand if 
the resistant phenotype can be transferred in before susceptible mice.  
2. Identifying bacterial signatures correlating with decreased 
susceptibility to enteric infections: 16S rRNA sequencing at 
different time points offer valuable information about intestinal bacteria 
associated with reduced susceptibility against S. Typhimurium and C. 
rodentium infections. 
3. Isolating intestinal bacteria conferring resistance: Isolating bacteria 
associated with higher resistance is required to verify correlation 
studies (referred to bullet point 2). Therefore, for isolation aerobic and 
anaerobic culturing methods are applied. Transferring isolated bacteria 
in susceptible mice and analyzing the susceptibility to gastrointestinal 
infections is important to show direct causality.  
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4. Characterizing bacterial mechanisms important for resistance: 
How intestinal bacteria affect pathogen colonization is analyzed to 
identify novel mechanisms critical for host protection against 
gastrointestinal pathogens. Therefore, mice deficient in important 
immune pathways and with additionally different microbiota 
compositions are used.  
 
The results of the study contribute to understand in more detail, which 
intestinal bacteria are important to confer colonization resistance to 
gastrointestinal pathogens. Moreover, the study provides insights into 
mechanisms to confer resistance to invading pathogens. Identifying the basic 
principles of immune regulation by commensals may allow harnessing their 
abilities to develop novel mucosal therapies for gastrointestinal infections.  
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Abbreviations 
 
 
A/E Attaching/effacing 
AMP Antimicrobial peptide 
 
CCL CC-chemokine ligand 
CCR C-C chemokine receptor type 
CD Cluster of differentiation 
CDC42 Cell division control protein 42 homolog 
CDI Clostridium difficile infection 
  
DC Dendritic cell 
  
EHEC Enterohaemorrhagic Escherichia coli 
EPEC 
Esp 
Enteropathogenic E.coli 
Escherichia secreted proteins 
  
FOXP3 Forkhead box protein 3 
FUT2 Fucosyltransferase 2 
  
GALT Gut-associated lymphoid tissue 
GATA Globin transcription factor 
  
H2S Hydrogen sulfide 
HCS Hematopoietic stem cell 
HIF Hypoxia-inducible factor 
  
IBD Inflammatory bowl disease 
IEC Intestinal epithelial cell 
IFN Interferon  
IgA Immunoglobulin A 
IL Interleukin 
ILC Innate lymphoid cell 
ILF Isolated lymphoid follicle 
  
LEE Locus of enterocyte effacement 
LP Lamina propria 
LPS Lipopolysaccharides 
  
M cells Microfold cells 
MALDI Matrix-assisted laser desorption/ionization 
MAMP Microbe-associated molecular pattern 
MS Mass spectrometry 
MyD88 Myeloid differentiation primary response gene 88 
  
NF-κB Nuclear factor κ-light-chain-enhancer of activated  
B-cells 
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NK cell Natural killer cell 
NLR NOD-like receptor 
NLRP6 
Nls 
NLR family pyrin domain containing 6 
Nuclear localization signal 
NOD Nucleotide-binding oligomerization 
NTP Deoxyribonucleotide triphosphates 
  
OTU Operational taxonomic units 
  
p.i. Post infection 
PAMP Pathogen-associated molecular pattern 
PP Peyer’s Patches 
PRR Pattern-recognition receptor 
PSA Polysaccharide A 
pTreg Peripherally-derived Treg 
  
Rac1 Ras-related C3 botulinum toxin substrate 1 
RAR Retinoic acid receptor 
Ras Rat sarcoma 
Rho Ras homologues 
Rig I Retinoic acid-inducible gene I 
RIP2 Receptor-interacting protein 2 
RLR Rig I-like receptor 
RORγt RAR-related orphan receptor γt 
ROS Reactive oxygen species 
 
SAA Serum amyloid A 
SCFA Short chain fatty acid 
SFB Segmented filamentous bacteria 
SipA Salmonella invasion protein A 
SPI Salmonella pathogenicity island 
 
T3SS Type III secretion system 
TCR T cell receptor 
TH 
Tir 
T helper lymphocyte 
Translocated intimin receptor 
TLR Toll-like receptor 
TNF Tumor necrosis factor 
TOF Time of flight 
Treg 
tTreg 
Regulatory T cells 
Thymus-derived Treg 
 
WGS Whole genome shotgun 
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Enhancement of IFNγ  production in CD4+ T cells by 
distinct commensals ameliorates Salmonella induced 
disease1 
 
2.1 Summary 
 
The microbiota contributes to colonization resistance against invading 
pathogens directly through competition for metabolites and production of 
inhibitory substances, as well as indirectly by priming protective immune 
responses. However, the identities of commensal bacteria that modulate host 
resistance and immune-mediated protection remain largely elusive. Using 
isogenic mouse lines with distinct microbiota profiles, we demonstrate that 
severity of disease induced by enteric Salmonella Typhimurium infection is 
strongly modulated by microbiota composition in individual lines prior to 
infection. Transferring a restricted community of eleven cultivable intestinal 
commensals from protected into susceptible mice decreases tissue 
colonization of S. Typhimurium and consequently severity of disease. We 
identify that reduced weight loss and prolonged survival depend on 
microbiota-enhanced IFNγ production, primarily in CD4+ T cells. In summary, 
we show that distinct microbiota members protect against intestinal 
Salmonella infection via induction of antibacterial IFNγ responses. 
 
                                            
1 Parts of the chapter have been published: Thiemann, S., Smit, N., Roy, U., Lesker, T. R., 
Gálvez, E. J. C., Helmecke, J., et al. (2017). Enhancement of IFNγ Production by Distinct 
Commensals Ameliorates Salmonella-Induced Disease. Cell Host & Microbe, 21(6), 682–
694.e5. 
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2.2 Introduction 
 
The human intestine harbors a dense and diverse microbial ecosystem, 
termed microbiota, which includes bacteria, archaea and eukaryotes. Over the 
past decades it has been established that the microbiota and their metabolites 
contribute to the physiology of the host during health and disease (Clemente 
et al., 2012; Ley et al., 2008). In the context of infections the resident 
microbiota contributes to limit colonization of the intestine with enteric 
pathogens, to prevent tissue invasion as well as to ensure proper activation of 
the immune system (Buffie and Pamer, 2013). Microbiota-mediated protection 
against pathogens can derive directly from commensal-pathogen interactions 
(e.g. nutrient competition, production of inhibitory substances, delivery of toxic 
products), or indirectly by enhancing protective immune-mediated 
antibacterial pathways (Caballero and Pamer, 2015). Disturbance of the 
resident microbiota and thus, altered susceptibility to infections can be 
induced by changes in diet and intake of medication (David et al., 2014; 
Ubeda et al., 2010). In particular, antibiotic use is associated with an 
increased susceptibility to several enteric infections, including Clostridium 
difficile infections and non-typhoidal Salmonella disease, which is at least 
partly mediated by altering the composition and functionality of resident 
bacterial populations (Bohnhoff and Miller, 1962; Doorduyn et al., 2006; Doré 
et al., 2004; Ng et al., 2014; Pavia et al., 1990; Sekirov et al., 2008).  
Non-typhoidal Salmonella (NTS) species, including Salmonella enterica spp. 
serovar Typhimurium (S. Typhimurium) belong to the family of Gram-negative 
Enterobacteriacea. Infections with NTS species are one of the leading causes 
of foodborne disease outbreaks and are the major bacterial cause of acute 
gastroenteritis, causing approximately 93.8 million cases and resulting in 
155,000 deaths per year (Majowicz et al., 2010). Upon ingestion with 
contaminated food, Salmonella has to compete with the resident intestinal 
microbiota and cope with the mucosal immune system to colonize the host. 
While the mucosal inflammation is required to eventually clear infection, 
Salmonella intriguingly benefits from it to outgrow commensal bacteria; e.g., 
utilizing specialized metal-uptake systems and inflammation-associated 
metabolites (Raffatellu et al., 2009; Stecher et al., 2007; Winter et al., 2010). 
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Vice versa, commensals are able to confer resistance against Salmonella, 
e.g. via production of inhibitory substances such as organic acids (Sun and 
O'Riordan, 2013). Moreover, one study identified that commensals contribute 
to immune-mediated protection against Salmonella via induction of 
antimicrobial peptides in Paneth cells limiting invasion and systemic 
dissemination (Vaishnava et al., 2008). Despite these advances it is not fully 
understood yet how the intestinal microbiota primes the host mucosal 
inflammatory response to combat against S. Typhimurium infection.  
Here, we employ mouse lines with distinct microbiota compositions and a 
mouse model of Salmonella-induced diarrhea that requires antibiotic induced 
disruption of direct colonization resistance. We demonstrate that severity of 
disease induced by S. Typhimurium is strongly dependent on the composition 
of the intestinal microbiota. We identify that resident intestinal bacteria from 
protected mice present before antibiotic treatment induce enhanced 
production of IFNγ by CD4+ T cells in the lamina propria and demonstrate that 
modulation of IFNγ production by the protective microbiota was necessary for 
augmented protection against S. Typhimurium. Finally, we show that transfer 
of 11 different bacterial species isolated from protected mice to susceptible 
mice recapitulated the protective effect by attenuating tissue invasion of S. 
Typhimurium. These results identify for the first time that modulation of IFNγ 
production by specific intestinal bacteria reduces the severity of Salmonella-
induced disease and thus potentially guide the development of novel probiotic 
interventions against enteric infections. 
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2.3 Methods 
2.3.1 Mice and microbiota manipulation by cohousing 
 
Wild type, Ifng-/- (Dalton et al., 1993) and Foxp3tm1Flv-IL-17tm1.1Flv-IFNγtm1Flv 
(Gagliani et al., 2015) (all on C57BL/6N background) mouse lines were 
rederived to SPF-1 microbiota conditions by embryo transfer and bred at the 
animal facilities of the Helmholtz Centre for Infection Research (HZI) under 
enhanced specific pathogen-free (SPF) conditions (Stehr et al., 2009). 
C57BL/6N SPF-2, SPF-3, SPF-4 and SPF-5 were purchased from different 
vendors (Charles River, Janvier, NCI and Taconic) and housed at the 
Helmholtz Centre for Infection Research for at least two weeks before the 
start of the experiment. After the initial screen, C57BL/6N SPF-2 mice were 
bred at the HZI. Germ-free C57BL/6NTac mice were bred in isolaters 
(Getinge) in the germ-free facility at the HZI. For cohousing with microbiota 
donor mice, donor and recipient mice were housed for at least four weeks 
together before infection experiments. SFB-monocolonized NOD.CB17-
Prkdcscid/J mice were bred in gnotobiotic isolators at the Hannover Medical 
School, Germany. Colonization of SPF-1 mice with SFB was achieved by 
cohousing for at least four weeks before infection experiments. Presence of 
SFB was investigated in fecal sample by PCR with SFB specific primers 
(Barman et al., 2008). All mice were provided with sterilized food and water ad 
libitum. Mice were kept under strict 12h light cycle and housed in groups of up 
to 6 mice per cage. For infections experiments, we used age- and sex-
matched mice between 10 and 14 weeks of age. Both female and male mice 
were used in experiments. All animal experiments have been performed in 
agreement with the local government of Lower Saxony, Germany. 
 
2.3.2 Fecal transplantation and microbiota reconstitution 
 
For fecal transplantation experiments, donor mice were euthanized, intestinal 
content was collected from large intestine, cecum and SI and pre-
homogenized in BBL thioglycollate media (BD Bioscience) by vortexing. 
Under anaerobic conditions, fecal content was homogenized using a 70µm 
sterile filter. After centrifugation (10 min, 500 g, 4 °C), fecal material was 
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resuspended in BHI medium (Sigma-Aldrich). A total of 200 µL of fecal 
transplant was given by oral gavage to recipient mice, which were starved 2 
hours prior. Control mice were given 200 µl of BHI medium. Four weeks after 
cohousing or fecal transplant feces were collected for 16S rRNA sequencing 
and gastrointestinal colitis was induced by infection with S. Typhimurium. For 
monocolonization experiments, germ-free C57BL/6 mice were housed in 
specific ventilated isocages (Techniplast). Mice were monocolonized with 200 
µl E. coli. One week after monocolonization, gastrointestinal colitis was 
induced by infection with S. Typhimurium. 
 
2.3.3 Isolation of fecal bacteria  
 
Fecal content of donor mice was collected, transferred to BBL thioglycollate 
media (BD Bioscience) and weighted. Fecal content was pre-homogenized by 
vortexing. Under anaerobic conditions, fecal content was passed through a 
70µm cell strainer and diluted to a concentration of 40mg/ml. Bacteria were 
cultured strictly anaerobically at 37°C for 2 days in an anaerobic chamber 
(Coy Laboratory) with following gas mix: 70% nitrogen, 20% CO2 and 10% 
hydrogen. Bacteria were isolated by using the most probable number (MPN) 
technique (Goodman et al., 2011). Specifically, in a 96-well plate 
homogenized sample was diluted in a range that maximal 30% of wells 
showed detectable growth. After 2 days, wells showing growth were mixed 
and then transferred into recipient mice (200 µl/mouse). SM medium was 
used for isolation and dilution processes: consists of 37g/L BHI (Sigma-
Aldrich), 1% vitamins supplement (ATCC MD-VS), 1% mineral supplement 
(ATCC MD-VS), 1% non essential amino acids (Biowest), 1mg of menadione, 
0.5g/L L-Cysteine HCl and 10% FCS, 4.2 mg/L Histidine, 1.2 mg/L Hematin 
and  1mg/L Resazurin (all Sigma-Aldrich).  
To identify the isolated bacteria, DNA was isolated via hot shot lysis: Hot shot 
lysis buffer (25mM NaOH and 0,5M EDTA in 500 mL dH2O, pH 12) was 
added to bacterial culture and mixture was heated for 45-60 min at 95ºC. 
Subsequently, neutralization buffer (3.2 g Tris-HCl in 1L dH20, pH 5) and 0.5 x 
TAE (10mL of 50x TAE in 1L dH2O) buffer was added. 16S rRNA gene was 
amplified using specific primer pairs: 27F (5’ AGAGTTTGATCMTGGCTCAG) 
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and 1492R (5’ TACGGYTACCTTGTTACGA CTT). The amplification program 
consisted of one cycle at 98°C for 3 min, followed by 30 cycles at 98°C for 10 
s, 55°C for 30 s and 72°C at 1 min 30 s. DNA was purified using MiniElute 96 
UF PCR Purification Kit (Qiagen) and subsequently sent to Sanger 
sequencing.  
 
2.3.4 Colitis model induced by infection with S. Typhimurium 
  
Naturally streptomycin-resistant S. enterica serovar Typhimurium SL1344 was 
used for infection experiments. Wild-type strain EM774 harbored an 
ampicillin-resistant plasmid and was used for infection experiments with 
ampicillin pre-treatment. Wild-type strain EM1046 contained a chromosomally 
integrated luxCDABE cassette, which confers kanamycin resistance (PMID 
19123992) and was used for infection experiments with streptomycin pre-
treatment. SL1344 strains EM951 and EM952 are deleted for the spi-1 
encoded injectisome (∆invH-sprB::Frt-Chloramphenicol-Frt) or spi-2 encoded 
injectisome (∆sseA-ssaU::Frt-Chloramphenicol-Frt), respectively, and harbor 
a chloramphenicol-resistance cassette. Salmonella strains were grown 
overnight at 37°C in lysogeny broth (LB), with either 50 µg/ml kanamycin or 
100 µg/ml ampicillin, then, diluted 1:100 in fresh medium, and subcultured for 
4 hours. Bacteria were washed twice in ice-cold phosphate-buffered saline 
(PBS) and then used for infection experiments.  
Water and food were withdrawn for 4 hours before mice were treated with 20 
mg / mouse of streptomycin by oral gavage (o.g.). Afterwards, mice were 
supplied with water and food ad libitum. 20 hours after streptomycin 
treatment, water and food were withdrawn again 4 hours before the mice were 
infected with 105 CFU of S. Typhimurium in 200 µl PBS. Drinking water ad 
libitum was supplied immediately and food 2 hours post infection (p.i.). Mice 
were weighted every day and survival was monitored.  
 
2.3.5 Analysis of bacterial loads in feces 
 
Fresh fecal samples were collected and weighted. Samples were 
homogenized in 1ml LB media by bead-beating with 1mm zirconia/silica 
beads twice for 25 sec using a Mini-Beadbeater-96 (BioSpec). To determine 
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CFUs, dilutions of homogenized samples were plated on LB and MacConkey 
plates, if necessary 50 µg/ml Kanamycin was added to media. 
 
2.3.6 Analysis of bacterial loads in fecal content and systemic organs 
 
All mice were euthanized by asphyxiation with CO2 and cervical dislocation at 
indicated time points. Intestinal tissues (small intestine, cecum, colon) and 
organs (mesenteric lymph nodes, spleen) were removed aseptically. To 
collect fecal content, organs were flushed with PBS. Organs were opened 
longitudinally, cleaned thoroughly with PBS and weighted. Organs and 
content were homogenized in PBS using a Polytron homogenizer 
(Kinemtatica). Dilutions of homogenized samples were plated on LB plates 
containing 50 µg/ml Kanamycin to determine CFUs.  
 
2.3.7 ELISA and Multiplex Analysis  
 
Intestinal tissues of mice infected with S. Typhimurium were washed and 
transferred into protease inhibitor (Complete, Roche) containing NP40 buffer 
at indicated time-points. The tissue was disrupted mechanically using bead-
beating four times for 1 min with 1mm zirconia/silica beads. Sample were 
stored at -80°C until analysis. Concentrations of cytokines were measured 
using commercial ELISA kit for IL-6 (BioLegend) and multiplex assay for all 
other cytokines (ProcartaPlex, eBioscience). To normalize protein 
concentration, Micro BCA protein assay Kit (Thermo Scientific) was used. 
ELISA, multiplex and BCA protein kit were used according to manufacturer’s 
instructions. 
 
2.3.8 Isolation of lymphocytes and flow cytometry  
 
To isolate lymphocytes of the lamina propria, density gradient centrifugation 
using Percoll was done as previously described (Nagano et al., 2012). Briefly, 
tissues were collected 20h p.i. and fecal content as well as Peyers patches in 
the SI were carefully removed. Tissues were opened longitudinally, organs 
were cleaned with PBS and then shaken in HBSS containing 2 mM EDTA for 
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20 min at 37°C. Tissues were cut into small pieces and incubated with 
digestion solution (RPMI 1640 containing 1% fetal bovine serum (FBS), 0.25 
mg/ml collagenase D, 0.5 U/ml dispase and 5 µg/ml DNase I) in a shaker for 
20 min at 37°C. Digested tissues were filtered through 70uM cell strainer 
(Falcon) and DMEM + 5% FBS was added to inactivate enzymes. The last 
two steps were repeated until all tissue was digested. After centrifugation, 
cells were resuspended in 4 ml of 40% Percoll (GE Healthcare) and overlaid 
on 4 ml of 80% Percoll. Percoll gradient separation was performed by 
centrifugation at 450 g for 25 min at 25°C. Cells in the interphase were 
collected and used as LP lymphocytes. The collected cells were then 
suspended in staining buffer containing PBS, 1% FBS and 2 mM EDTA. The 
following antibodies were used: AlexaFluor-700 labeled anti-CD45 (30-F11), 
APC labeled anti-TCRgd (GL3), BV650 labeled anti-CD3 (17A2), BV785 
labeled anti-CD4 (RM4-5) (Biolegend). To distinguish live dead cells 
AlexaFluor-350 NHS Ester (Life Technologies) was used. Flow cytometry 
analysis was performed using a BD LSRFortessa (BD Biosciences) and 
FlowJo software (TreeStar Inc.). 
 
2.3.9 DNA isolation and 16S rRNA analysis 
 
Fresh stool samples of mice were collected and immediately stored at -20°C. 
DNA was extracted according to established protocols using a method 
combining mechanical disruption (bead-beating) and phenol/chloroform-based 
purification (Turnbaugh et al., 2009). Briefly, sample was suspended in a 
solution containing 500µl of extraction buffer (200 mM Tris, 20mM EDTA, 
200mM NaCl, pH 8.0), 200µl of 20% SDS, 500µl of phenol:chloroform:isoamyl 
alcohol (24:24:1) and 100µl of 0.1 mm zirconia/silica. Samples were 
homogenized twice with a bead beater (BioSpec) for 2 min. After precipitation 
of DNA, crude DNA extracts were resuspended in TE Buffer with 100µg/ml 
RNase and column purified to remove PCR inhibitors (BioBasic). Amplification 
of the V4 region (F515/R806) of the 16S rRNA gene was performed according 
to previously described protocols (Caporaso et al., 2011). Samples were 
sequenced on an Illuminia MiSeq platform (PE250). Filtering of sequences for 
low quality reads and barcode-based binning was performed by using QIIME 
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v1.8.0 (Caporaso et al., 2010). Reads were clustered into 97% ID OTUs using 
Open-reference OTU picking with UCLUST (Edgar, 2010) followed by 
taxonomic classification using the RDP Classifier executed at 80% bootstrap 
confidence cut off (Wang et al., 2007). Sequences without matching reference 
dataset, were grouped as de novo using UCLUST. Phylogenetic relationships 
between OTUs are determined using FastTree to the PyNAST alignment 
(Price et al., 2010). The OTU absolute abundance table and mapping file are 
used for statistical analyses and data visualization in the R statistical 
programming environment package phyloseq (McMurdie and Holmes, 2013). 
To determine bacterial OTUs that explained differences between microbiota 
settings, linear discriminant analysis (LDA) effect size (LEfSe) method were 
used (Segata et al., 2011). OTUs with Kruskal-Wallis test <0.05 and LDA 
scores >4.0 were considered informative. 
 
2.3.10 Evolutionary relationships of taxa  
 
Phylogenetic tree was created using the Neighbor-Joining method (Saitou and 
Nei, 1987). The optimal tree with the sum of branch length = 1.37487100 is 
shown. The percentage of replicate trees in which the associated taxa 
clustered together in the bootstrap test (10000 replicates) is shown next to the 
branches (Zharkikh and Li, 1995). The tree is drawn to scale, with branch 
lengths in the same units as those of the evolutionary distances used to infer 
the phylogenetic tree. The evolutionary distances were computed using the 
Maximum Composite Likelihood method (Tamura et al., 2004) and are in the 
units of the number of base substitutions per site. Evolutionary analyses were 
conducted in MEGA6 (Tamura et al., 2013). 
 
2.3.11 Statistical analysis 
 
Data were analyzed with GraphPad Prism v6.0 and R statistical programming 
environment. Data are expressed as mean ± SEM. Differences were analyzed 
by Student’s t test and ANOVA. P values indicated represent a non-
parametric Mann-Whitney U test or Kruskal-Wallis test comparison of totals 
between groups. P values lower than 0.05 were considered as significant: 
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 
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2.4 Results 
 
2.4.1 Isogenic mouse lines feature different susceptibility towards         
S. Typhimurium infection 
 
It has been noted that the composition of the intestinal microbiota is 
associated with the degree of colonization resistance and severity of 
gastrointestinal disease during enteric S. Typhimurium infection, however the 
identity of bacteria contributing to this phenotype has largely remained 
unknown (Stecher et al., 2010). In order to identify specific bacteria that 
modulate Salmonella infection, we investigated susceptibility to disease 
induced by oral infection with S. Typhimurium using isogenic mouse lines with 
distinct composition of the microbiota. Age- and gender-matched C57BL6/N 
mice were obtained from different specific pathogen free (SPF) breeding 
facilities (SPF-1 – SPF-3) and housed in our vivarium for at least two weeks to 
allow adjustment to environmental conditions such as diet. Subsequently, 
mice were pretreated with a single dose of streptomycin and infected 24 hours 
later with S. Typhimurium (105 CFU) by oral gavage (Figure 2.1 A).  
Figure 2.1 - Isogenic mouse lines from different vendors show distinct susceptibility 
during S. Typhimurium infection. (A) SPF-1, SPF-2 and SPF-3 Mice were treated with 
streptomycin (strep) 1 day prior infection and infected o.g. with 105 CFU Salmonella 
Typhimurium (S.T.). (B-D) Body weight was recorded during infection (B) and body weight of 
individual mice on day 1 p.i. is shown (C). Survival of mice was examined (D). Results 
represent n=6-25 mice/group as mean ± SEM from at least two independent experiments. P 
values indicated represent a Mann-Whitney U test comparison of totals between groups. 
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.  
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SPF-2 and SPF-3 mice displayed in contrast a lower disease severity upon 
infection compared to SPF-1 mice as demonstrated in decreased weight loss 
and prolonged survival (Figure 2.1 B-D).  
First, we performed 16S rRNA gene amplicon sequencing from fecal DNA at 
baseline before antibiotic treatment to compare the microbiota composition. 
Analysis of β-diversity revealed a significant difference between the microbial 
communities of SPF-1, SPF-2 and SPF-3 mice with samples clustering 
distinctively according to the mouse line, respectively (Figure 2.2 A).  
 
Notably, α-diversity varied between the mouse lines and specifically, SPF-1 
mice had lower Shannon (species richness combined with abundance and 
evenness) and Chao1 indices (species richness) than SPF-2 and SPF-3 mice 
Figure 2 
A B 
C D 
Chao1 Shannon
0
500
1000
1500
2
3
4
5
ASF
SPF-1
SPF-2
SPF-3
ASF
SPF-1
SPF-2
SPF-3
Microbiota
Al
ph
a 
Di
ve
rs
ity
 M
ea
su
re Microbiota
SPF-1
SPF-2
SPF-3
ASF
A
S
F 
S
P
F-1 
S
P
F-2 
S
P
F-3 
-0.4
-0.2
0.0
0.2
-0.25 0.00 0.25 0.50
Axis.1   [40.3%]
Ax
is.
2 
  [
16
.1
%
] Genotype
B/6N
Microbiota
SPF-1
SPF-2
SPF-3
Chao1 Shannon
0
500
1000
1500
2
3
4
5
ASF
SPF-1
SPF-2
SPF-3
ASF
SPF-1
SPF-2
SPF-3
Microbiota
Al
ph
a D
ive
rsi
ty 
Me
as
ur
e Microbiota
SPF-1
SPF-2
SPF-3
ASF
A
S
F 
S
P
F-1 
S
P
F-2 
S
P
F-3 
SP
F-
1
SP
F-
2
SP
F-
3
SP
F-
1
SP
F-
2
SP
F-
3
SP
F-
1
SP
F-
2
SP
F-
3
105
1010
C
FU
/g
 fe
ce
s
Enterobacteriaceae
Lac+
S.T.
BSL d1 p.i. d2 p.i. GF GF + E. coli
75
85
95
105
B
od
y 
w
ei
gh
t (
%
)
 1 day p.i.
**
Figure 2.2 - Isogenic mouse lines from different vendors reveal distinct microbial 
communtiy. (A and B) Fecal microbiota of SPF-1, SPF-2 and SPF-3 mice was analyzed at 
steady state (BSL) using 16S rRNA analysis. Analysis of β-diversity using Bray-Curtis 
dissimilarity matrix and PCoA plot (A) as well as α-diversity using Shannon and Chao1 index 
are displayed (B). (C) Fecal samples prior infection as well as 1 day p.i. and 2 days p.i. were 
cultured on MacConkey agar with and without kanamycin. Lactose-fermenting (Lac+) 
colonies represent Escherichia coli. Non-lactose-fermenting bacteria (Lac-) colonies 
represent S.T. (E) Escherichia coli, isolated of SPF-3, was transferred in germ-free mice and 
body weight was analyzed 1 day p.i. Results represent n=3-8 mice/group from one 
experiment (C, D) or from at least two independent experiments (A, B) as mean ± SEM. 
Dashed line indicate the limit of detection. P values indicated represent a Mann-Whitney U 
test comparison of totals between groups. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 
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(Kruskal-Wallis rank sum test, p-value= 3.387e-14) (Figure 2.2 B). 
Nonetheless, SPF-1, SPF-2 and SPF-3 mice all displayed a high degree of 
complexity compared to the Altered Schaedler Flora (ASF), a low diversity 
community containing a mixture of only 8 bacterial strains and thus, can be 
consequently considered as high-complexity communities (Dewhirst et al., 
1999). 
Commensal Enterobacteriaceae (e.g. Escherichia coli) have been identified 
as competitors of invading S. Typhimurium (Deriu et al., 2013; Lupp et al., 
2007; Stecher et al., 2007). To analyze whether Enterobacteriaceae are 
present in our mouse lines, we quantified the level of Enterobacteriaceae 
before and during infection by culturing feces on MacConkey agar that 
enriches Gram-negative enteric bacilli and enables differentiation of colonies 
according to the ability to ferment lactose. Non-lactose fermenting colonies 
(Lac-), which were absent in all mouse lines before infection, appeared after 
infection and presumably consisted exclusively of S. Typhimurium as 
suggested by equal CFU numbers on S. Typhimurium-selective kanamycin-
containing MacConkey plates (Figure 2.2 C, data not shown). Despite the 
differences in weight loss between mouse lines, comparable numbers of S. 
Typhimurium CFUs were detected in feces collected from SPF-1, SPF-2 and 
SPF-3 mice (Figure 2.2 C). Lactose-utilizing colonies (Lac+) were detected 
routinely at low numbers (105 CFU/g feces) in SPF-3 mice before infection, 
but were absent in SPF-1 and SPF-2 mice. During infection Lac+ colonies 
expanded in SPF-3 mice to comparable numbers as S. Typhimurium (Figure 
2.2 C) and were not detected in SPF-1 and SPF-2 mice. We isolated the Lac+ 
colonies of SPF-3 mice and identified them by Sanger sequencing of their 
16S rRNA gene as Escherichia coli. To examine if E. coli recovers the 
resistant SPF-3 phenotype, we transferred the isolated E. coli strain of SPF-3 
mice into germ-free (GF) mice and induced S. Typhimurium disease 
according to Figure 2.1 A. Analyzing body weight 1 day p.i. revealed that 
gnotobiotic mice solely colonized with E. coli showed a lower susceptibility to 
S. Typhimurium (Figure 2.2. D). Our results demonstrate that SPF-2 mice are 
in contrast to SPF-3 mice devoid of Enterobacteriaceae prior to infection and 
did not show any enterobacterial bloom, which affects Salmonella infection. 
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Hence we conclude that protection seen in SPF-2 mice is independent of 
Enterobacteriaceae, but dependent on yet unidentified commensal bacteria.  
 
2.4.2. Altered susceptibility to S. Typhimurium gastroenteritis is 
mediated by SPF-2 microbiota  
 
To formally exclude the possibility that genetic differences between SPF-1 
and SPF-2 mice as a result of being derived from different C57BL6/N sub-
lines or acquired by spontaneous mutation during inbreeding are responsible 
for the phenotype, we cohoused SPF-1 and SPF-2 mice with germfree 
C57BL6/NTac mice for 4 weeks before infection (Figure 2.3 A). 16S rRNA 
sequencing confirmed that recipient exGF mice harbored a similar microbiota 
composition as their respective SPF-1 or SPF-2 donor after four weeks of 
cohousing (Figure 2.3 B).  
 
Figure 2.3 - Differences in disease severity are microbiota-driven. (A) C57BL6/NTac 
germ-free mice (GF) were cohoused with SPF-1 and SPF-2 for 4 weeks and infected with 
S.T. (B) Fecal microbiota of single-housed (SPF-1, SPF-2) and cohoused (GF(SPF-1), 
GF(SPF-2)) mice were analyzed after 4 weeks of cohousing using 16S rRNA analysis 
including Bray-Curtis dissimilarity matrix and PCoA plot. (C-E) Body weight was measured 
over time of infection (C) and significances in body weight between single-housed and 
cohoused were analyzed 1 day post infection (p.i.) (D). Survival of mice was examined during 
the infection (E). Results represent one independent experiment n=5-6 mice/group as mean ± 
SEM. P values indicated represent a Mann-Whitney U test comparison of totals between 
groups. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 
 
Strikingly, weight loss and survival of the recipient GF mice after infection with 
Salmonella were identical to the respective cohousing partners, indicating that 
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differences in disease severity are indeed microbiota-driven (Figure 2.3 C-E). 
Next, we examined how mixing of these microbial communities influenced the 
protective and susceptible phenotypes. Therefore, SPF-1 and SPF-2 mice 
were cohoused to allow exchange of the microbiota between mouse lines 
(Figure 2.4 A).  
 
Figure 2.4 - Protective phenotype is transferable by cohousing. (A) SPF-1 and SPF-2 
were cohoused for 4 weeks and infected with S.T. (B) Fecal microbiota of single-housed 
(SPF-1, SPF-2) and cohoused (SPF-1 coh, SPF-2 coh) mice was analyzed after 4 weeks of 
cohousing using 16S rRNA analysis including Bray-Curtis dissimilarity matrix and PCoA plot. 
(C-E) Body weight of single-housed and cohoused mice was recorded during infection (C) 
and body weight of individual mice on day 1 p.i. is displayed (D). Survival of mice was 
examined (E). Results represent n=6-14 mice/group from at least two independent 
experiments as mean ± SEM. P values indicated represent a Mann-Whitney U test 
comparison of totals between groups. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. 
 
Notably, 16S rRNA sequencing revealed that upon cohousing the microbiota 
in SPF-1 and SPF-2 mice largely resembled the microbiota in SPF-2 mice 
before cohousing (Figure 2.4 B). Comparison of body weight loss and survival 
between cohoused and single-housed mice showed that SPF-1 mice 
cohoused with SPF-2 mice (SPF-1 coh) phenocopied SPF-2 mice further 
corroborating that specific components of the SPF-2 microbiota are 
responsible for decreased severity of S. Typhimurium-induced disease 
(Figure 2.4 C-E). To analyze if this phenotype could also be transferred by 
fecal transplantation, SPF-1 mice were transferred with homogenized fecal 
content of SPF-2 mice (donor) by oral gavage (Figure 2.5 A). Analysis of 
microbial composition after 4 weeks revealed a similar microbiota in SPF-1 
mice, which received a fecal transplant of SPF-2 mice, compared to SPF-2 
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mice (Figure 2.5 B). In addition, SPF-1 mice, which received a fecal transplant 
from SPF-2 mice, revealed a similar disease progression during Salmonella 
infection compared to SPF-2 mice showing diminished body weight loss and 
higher survival rate (Figure 2.5 C-D). These results show that it is indeed the 
SPF-2 microbiota that is able to protect against S. Typhimurium. 
 
Figure 2.5 - Protective phenotype is transferable by fecal transplantation. (A) Fecal 
content of SPF-2 was transferred by fecal transplant (FT) to SPF-1 (FT SPF-2) mice and mice 
were infected after 4 weeks with S.T. (B) Fecal microbiota was analyzed after 4 weeks of FT 
by 16S rRNA analysis using Bray-Curtis dissimilarity matrix and PCoA plot. (C-E) Body 
weight of mice was recorded during infection (C) and body weight of individual mice on day 1 
p.i. is displayed (D). Survival of mice was examined (E). Results represent n=6-14 mice/group 
from at least two independent experiments as mean ± SEM. P values indicated represent a 
Mann-Whitney U test comparison of totals between groups. *p<0.05, **p<0.01, ***p<0.001, 
****p<0.0001.  
 
2.4.3 Microbiota mediated protection is associated with decreased 
tissue colonization and independent of direct colonization resistance 
 
After oral infection S. Typhimurium first colonizes the intestinal lumen, where 
it competes with the commensal microbiota (Kaiser et al., 2012). 
Subsequently, S. Typhimurium infects epithelial cells and invades the lamina 
propria triggering intestinal inflammation. Finally, S. Typhimurium spreads via 
the lymphatic vessels to the mesenteric lymph nodes and then into other 
systemic organs as spleen and liver resulting in lethal systemic infection in 
susceptible hosts (Barthel et al., 2003). To start dissecting how the microbiota 
in SPF-2 mice ameliorates disease, we quantified Salmonella colonization in 
the intestinal lumen and tissue (6, 20, and 44 hours p.i.). Comparing SPF-1 
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and SPF-2 mice we detected similar numbers of CFUs in the lumen of 
gastrointestinal regions at all analyzed time points (6, 20, and 44 hours p.i.) 
(Figure 2.6 A-H). Unlike the comparable Salmonella loads in the lumen of 
SPF-1 and SPF-2 mice, we detected lower numbers of CFUs in the tissue of 
SPF-2 mice compared to SPF-1 mice; up to 100-fold lower numbers of CFUs 
in the SI already at all analyzed time points and five-fold differences in the 
cecum after 20 hours p.i. (Figure 2.6 B, 2.6 E). In the SI the largest difference 
was observed in the terminal ileum (Figure 2.6 H). Based on these results, we 
conclude that severity of disease correlates not with the luminal colonization 
of S. Typhimurium, but rather with higher pathogen invasion.   
 
 
Figure 2.6 - Bacterial load of S. Typhimurium at different time points. (A-G) Salmonella 
infected mice were sacrificed 6 hours p.i. (A, D), 20 hours p.i. (B, E, G) and 44 hours p.i. (C, 
F). Number of S. Typhimurium CFUs was determined in luminal content (A-C) and tissue (D-
F) of small intestine (SI), cecum and colon as well as in mesenteric lymph nodes (MLN) and 
spleen (G). (H) Mice were sacrified 6 hours p.i. and small intestine was divided in four same 
sized parts as indicated: Duodenum (Duo), jejunum (Jej), proximal ileum (pIl) and terminales 
ileum (tIl). Number of S. Typhimurium was determined. Results represent n=5-13 mice/group 
as mean ± SEM from one (H) or at least two independent experiments (A-G). Dashed line 
indicates the limit of detection. P values indicated represent a Mann-Whitney U test 
comparison of totals between groups. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 
 
S. Typhimurium is able to invade the host tissue and eventually induce 
intestinal inflammation via different routes, in which type III injectisome 
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systems encoded on either the Salmonella Pathogenicity Islands (SPI)-1 or -2 
play an essential role (Hapfelmeier et al., 2005). SPI-1 is essential for 
induction of inducing uptake by enterocytes, while SPI-2 is required for 
survival and replication in phagocytic cells in the lamina propria. In order to 
identify whether induction of inflammation via any of the two pathways 
contributes to altered disease susceptibility, we infected SPF-1 and SPF-2 
mice with wild type (WT) and Dspi-1 mutant S. Typhimurium. In contrast to 
infection with the WT strain, no difference in weight loss and survival was 
observed between SPF-1 and SPF-2 mice after infection with Dspi-1 mutant 
strain, indicating that induction of inflammation downstream of SPI-1, i.e. 
infection of enterocytes, is affected by the SPF-2 microbiota (Figure 2.7 A). 
 
Figure 2.7 - Higher S. Typhimurium susceptibility correlates with increases tissue 
invasion via SPI-1 type III secretion system. (A and B) Body weight of mice infected with S. 
Typhimurium wild type (wt) as well as with S. Typhimurium deficient in SPI-1 (A) and SPI-2 
(B) are shown. Results represent n=5-13 mice/group from at least two independent 
experiments as mean ± SEM. P values indicated represent a Mann-Whitney U test 
comparison of totals between groups. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.  
 
Notably, upon infection Dspi-2 mutant S. Typhimurium SPF-1 and SPF-2 mice 
displayed the same difference of weight loss between the mouse lines early 
during infection (day 1 p.i.) (Figure 2.7 B). As previously reported, mice 
subsequently recovered and did not succumb to infection (Raupach et al., 
2003). These results strongly suggest that the microbiota in SPF-2 mice does 
not protect the host via direct competition with S. Typhimurium in the lumen 
but rather by limiting the ability of S. Typhimurium to induce intestinal 
inflammation via the SPI-1 encoded injectisome.    
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2.4.4 Microbiota mediated modulation of host’s IFNγ  production is 
crucial for colonization resistance 
 
Already at early phases of the infection, distinct antimicrobial molecules and 
cytokines produced by the host act in concert for defense against S. 
Typhimurium (Kaiser et al., 2012). We hypothesized that differences in 
microbiota composition between SPF-1 and SPF-2 mice would result in 
distinct immune responses against S. Typhimurium infection that would 
explain the different colonization of intestinal tissues. Comparison of cytokine 
profiles in the cecum 20 hours after S. Typhimurium infection readily revealed 
several cytokines that were either upregulated in SPF-1 (IL-6, IL-1a and IL-
17F) or SPF-2 mice (IFNγ , IL-27 and IL-23) (Figure 2.8).  
 
Figure 2.8 - Resident bacteria regulate distinct cytokine expression profile during S. 
Typhimurium infection. Streptomycin pretreated SPF-1 and SPF-2 mice were infected with 
105 S. Typhimurium (S.T.) by oral gavage (o.g.). Mice were sacrificed 12 hours post infection 
(p.i.) and cecum was analyzed for interferon (IFN)-γ, interleukine (IL)-27, IL-23, IL-1α, IL-6, IL-
17F, IL-1β, IL-12p70, IL-18, IL-22 by ELISA. Data derive from one experiment as mean ± 
SEM. P values indicated represent a Mann-Whitney U test between groups. *p<0.05, 
**p<0.01, ***p<0.001, ****p<0.0001  
 
Enhanced levels of IL-6 in SPF-1 mice may reflect the increased bacterial 
colonization in the tissue. In contrast, higher secretion of IFNγ , a cytokine that 
has been shown to contribute to host defense against S. Typhimurium (Rhee 
et al., 2005), specifically in SPF-2 mice, may reflect microbiota-modulated 
enhanced protective immune responses. In order to determine the cellular 
source of IFNγ  during Salmonella infection, we employed a cytokine reporter 
mouse that allows for detection of IL-17 and IFNγ  production in vivo by 
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monitoring the expression of fluorescent proteins in target cells by flow 
cytometry without manipulation ex vivo. These mice were bred harboring the 
SPF-1 microbiota and the SPF-2 microbiota was introduced by fecal 
transplantation analogous to Figure 2.5 A. In CD3- lymphocytes, including NK 
cells and ILCs, the frequency of IFNγ-producing cells was similar between 
SPF-1 and SPF-2 reporter mice in the cecum and SI (Figure 2.9 A-B).  
 
Figure 2.9 - Resident bacteria modulate IFNγ production by CD4+ T cells. Reporter mice 
for IFNγ and IL-17 were rederived by embryo transfer and SPF-2 microbiota was transferred 
by fecal transplantation. Streptomycin pretreated mice were infected with 105 S. Typhimurium 
(S.T.) by oral gavage (o.g.). On day 1 p.i. cells were isolated from the lamina propria and 
analyzed by flow cytometry. Representative flow cytometry plots showing the frequency of 
CD4+ T cell producing IFNγ and IL-17 in small intestine (A) and cecum (B). Graphs represent 
frequency (%) of IFNγ+ and IL-17A+ cells amongst CD4+ cells, as well as CD3- and TCRγδ+ 
cells in small inestine (A) and cecum (B). Data are shown for representative out of three 
independent experiments with n=3-4 mice per group as mean ± SEM. P values indicated 
represent unpaired t test comparison of totals between groups. *p<0.05, **p<0.01, 
***p<0.001, ****p<0.0001, ns – not significant 
 
However, a significant increase in the frequency of IFNγ-producing cells was 
detected in CD3+ lymphocytes in SPF-2 mice, particularly of CD4+ T cells but 
not TCRγδ+ cells (Figure 2.9 A-B). Additionally, in SPF-2 mice increased 
frequencies of CD4+ T cells in the SI, but not cecum, produced IL-17A (Figure 
2.9 A-B). In order to test whether enhanced IFNγ  production in SPF-2 mice 
contributes to the microbiota-mediated decrease in severity of Salmonella-
induced disease, we decided to test the effect of the SPF2 microbiota in IFNγ  
deficient mice. To do so, we rederived Ifng-/- mice into the SPF-1 microbiota 
using embryo-transfer into foster mothers colonized with the SPF-1 
microbiota. Ifng-/- mice with the SPF-2 microbiota were generated by fecal 
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transplantation as described in Figure 2.10 A. Importantly, comparison of 
microbiota composition of both WT and Ifng-/- mice with either the SPF-1 or 
SPF-2 microbiota, revealed no differences between the two genotypes (Figure 
2.10 B). Strikingly, S. Typhimurium infected Ifng-/- mice harboring either the 
SPF-1 or the SPF-2 microbiota showed similar weight loss and survival, while 
control mice showed the same microbiota-dependent differences as 
previously described (Figure 2.10 C-E). This strongly suggests that the SPF-2 
microbiota requires IFNγ  to protect the host and that enhanced IFNγ  
production is derived from CD4+ T cells. 
 
Figure 2.10 - Bacteria-modulated IFNγ is required for augmented protection towards S. 
Typhmurium. (A-E) Ifng-/- mice were rederived by embryo transfer (Ifng-/- SPF-1). SPF-2 
microbiota was transferred by fecal transplantation (FT) (Ifng-/- SPF-2) and mice were infected 
4 weeks later (A). Composition of the fecal microbiota was analyzed prior to streptomycin 
treatment by 16S rRNA analysis using Bray-Curtis dissimilarity matrix and PCoA plot (B). (C-
E) Body weight (C) and survival (E) during course of infection are displayed as well as body 
weight of individual mice on day 1 p.i. is shown (D). Data are pooled with n=15-16 mice from 
two independent experiments as mean ± SEM. P values indicated represent a Mann-Whitney 
U test comparison of totals between groups. 
 
2.4.5 Identification of microbial signatures that are linked with increased 
resistance towards Salmonella infection 
 
In order to identify specific bacteria associated with resistance to Salmonella 
induced disease, we characterized the microbiota composition using 16S 
rRNA sequencing from fecal samples at baseline before the experiment 
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(BSL), after streptomycin treatment, and 1 day p.i. The microbial composition 
of SPF-1 and SPF-2 mice clustered differently before treatment, whereas it 
showed overall more similarity after streptomycin treatment and S. 
Typhimurium infection (Figure 2.11 A-B, 2.12).  
Figure 2.11 - Changes of the microbiota composition of SPF-1 and SPF-2 mice during 
infection. (A and B) Composition of the microbiota of SPF-1 and SPF-2 mice was analyzed 
by 16S rRNA analysis before treatment (BSL) (n=38-49), 1 day after streptomycin treatment 
(n=16-24) and 1 day p.i. with S. Typhimurium (n=14-19). Bray-Curtis dissimilarity matrix and 
PCoA plot demonstrate distances between communities at different time points (A). Relative 
abundances of bacterial families are shown and grouped according to their phylum; bars 
represent the mean of all mice within the group (B). Results represent more than 3 
independent experiments.  
 
Comparing the community in SPF-1 and SPF-2 mice using LEfSe (Segata et 
al., 2011),  revealed that the SPF-1 microbiota at baseline is characterized by 
a significantly higher relative abundance of Firmicutes, including Clostridia 
(Families: Lachnospiraceae and Clostridiaceae) and Bacilli (Families: 
Lactobacillaceae and Turicibacteriaceae), but also Bacteroidia as 
Porphyromonadaceae and Rikenellaceae (Figure 2.13 A). SPF-2 mice 
featured a significantly higher relative abundance of Bacteroidetes (Families: 
S24-7 and Prevotallaceae) as well as with bacteria of the family 
Verrucomicrobiaceae. After streptomycin treatment, bacteria from 
Bacteroidales were diminished and the presence of bacteria from the family 
Coriobacteriaceae correlated with the protective phenotype of SPF-2 mice (Figure 
2.12, 2.13 B). 
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Figure 2.12 - Composition of intestinal microbiota at OTU level during different phases 
of S. Typhimurium infection. Heatmap of relative abundance of bacterial OTUs (≥97% 
sequence similarity, >0.05% relative abundance) sorted by family and class as well as SPF-1 
and SPF-2 at baseline (n=38-49), after streptomycin treatment (16-24) and Salmonella 
infection 1 day p.i. (14-19). Results represent more than 3 independent experiments.  
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Figure 2.13 - Microbial signatures associated with amelioration of S. Typhimurium 
induced disease. Statistically significant differences between SPF-1 and SPF-2 before 
treatment (C), 1 day after streptomycin treatment (D) and 1 day p.i. (E) was analyzed using 
LEfSe (Kruskal-Wallis test p<0.05, LDA 4.0).  
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Moreover, 1 day p.i. we detected a significantly higher relative abundance of 
Enterococcaceae, Streptococcaceae and Enterobacteriaceae in SPF-2 mice 
(Figure 2.13 C). To investigate whether the resistant phenotype is linked to 
communities observed after pretreatment of mice with streptomycin, we 
pretreated SPF-1 and SPF-2 mice with ampicillin, which targets a different 
spectrum of bacteria. Strikingly, SPF-2 mice were protected relative to SPF-1 
mice also using ampicillin as antibiotic pretreatment, despite large differences 
in the bacterial communities were observed after ampicillin compared to 
streptomycin treatment (Figure 2.14 A-C). These results suggest that 
members of the SPF-2 microbiota influence host resistance prior to antibiotic 
treatment. 
 
 
Figure 2.14 - Streptomycin and ampicillin treatment before infection reveals different 
microbiota composition but similar phenotype during infection. (A-C) Ampicillin 
pretreated SPF-1 and SPF-2 mice were infected with 105 S. Typhimurium (S.T.). Body weight 
(A) and survival (B) are shown. (C) Composition of the fecal microbiota of SPF-1 and SPF-2 
was analyzed by 16S rRNA analysis before treatment (none), 1 day after streptomycin 
treatment and 1 day after ampicillin treatment. Bray-Curtis dissimilarity matrix and PCoA plot 
was used. Results represent n=11-15 mice/group as mean ± SEM pooled from two 
independent experiments. P values indicated represent a Mann-Whitney U test comparison of 
totals between groups. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 
 
2.4.6 Cultivable bacteria derived from the SPF-2 microbiota are 
responsible for the protective phenotype  
 
Differentiation of CD4+ T cells in the intestine is influenced by distinct 
members of the microbiota, e.g. induction of Th17 cells is supported by the 
presence of segmented filamentous bacteria (SFB) (Ivanov et al., 2009). 
Notably, it has also been reported that SFB increase IFNγ production from 
CD4+ T cells (Gaboriau-Routhiau et al., 2009). Since we observed that the 
frequency of IL-17 and IFNγ-producing CD4+ was increased in SPF-2 mice, 
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we investigated whether transfer of SFB into SPF-1 mice was able to reduce 
susceptibility to S. Typhimurium infection. Therefore, we cohoused SFB 
monocolonized donor mice with SPF-1 recipient mice for 4 weeks after which 
we confirmed that SFB successfully colonized SPF-1 mice (Figure 2.15 A). 
We then infected SPF-1 and SPF-1+SFB mice with Salmonella and analyzed 
body weight and survival. Compared to the SPF-2 microbiota containing SFB 
and other bacteria, transfer of SFB alone is unable to induce the protective 
phenotype (Figure 2.15 B-C).  
 
To identify bacteria able to transfer the protective SPF-2 phenotype, we 
cultured bacteria from the fecal content of SPF-2 mice (Goodman et al., 
2011). Specifically, in a 96-well plate we diluted homogenized fecal content 
samples of SPF-2 mice in a range that maximal only 30% of wells showed a 
detectable growth after 2 days under anaerobic conditions (Figure 2.16 A). 
From one plate that showed growth in the desired range we identified the 
growing bacteria in each individual well by Sanger sequencing of the 16S 
rRNA gene. We recovered 11 different isolates from the following bacterial 
families: Prevotellaceae, Bacteroidaceae, S-24/7, Lactobacillaceae and 
Lachnospiraceae (Figure 2.16 B). In parallel, we transferred the content of 
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A 
B 
0 1 2 3
75
85
95
105
Time (d)
B
od
y 
w
ei
gh
t (
%
)
SPF-1
SPF-1 + SFB
SPF-2
***
0 2 4 6
0
50
100
Time (d)
Su
rv
iv
al
 (%
)
SPF-1
SPF-1 + SFB
SPF-2
**
**
SPF-1 SPF-1 + SFB SPF-2 SFB M H2O 
C 
Figure 2.15 - Segmented filamentous bacteria (SFB) are dispensable for modulating 
protection to S. Typhimurium infection. (A-C) Monocolonized SFB mice were cohoused 
with SPF-1 mice (SPF-1 + SFB) for 4 weeks and mice were infected with S. Typhimurium. At 
baseline, abundance of SFB in mice was analyzed by PCR (A). Upon infection, body weight 
(B) and survival (C) was measured. Results represent n=4-15 mice/group of one experiments 
as mean ± SEM. P values indicated represent a Mann-Whitney U test comparison of totals 
between groups. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.  
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wells displaying growth to SPF-1 mice and after 4 weeks, analyzed the 
composition of the fecal microbiota using 16S rRNA sequencing. The 
microbiota composition in mice receiving the isolates was distinct from SPF-1 
and SPF-1 mice which were transplanted with the SPF-2 community (Figure 
2.16 C-D). 
 
Figure 2.16 - Isolation of bacteria from fecal content of protected mice. (A-D) Culture 
collections were generated from fecal content of SPF-2 mice. Isolated bacteria were 
transferred to SPF-1 (SPF-1 + cult bacteria). As control whole SPF-2 community was 
transferred by fecal transplantation (SPF-1(FT SPF-2)). After 4 weeks mice were pretreated 
with streptomycin (strep) and infected with 105 CFU S. Typhimurium (S.T.) (A). (B) 
Phylogenetic tree of cultured bacteria of SPF-2 from full-length 16S rRNA gene sequences. 
(C) Fecal microbiota was analyzed after 4 weeks of transplantation by 16S rRNA analysis 
using Bray-Curtis dissimilarity matrix and PCoA plot. (D) Relative abundances of bacterial 
families are shown and grouped according to their phylum; bars represent the mean of all 
mice within the group. Results represent n=4-15 mice/group from one experiments.  
 
Upon infection with Salmonella SPF-1 mice receiving the isolated bacteria 
had a similarly delayed disease progression as SPF-1 mice transplanted with 
the full SPF-2 community, as indicated by reduced body weight loss and 
enhanced survival compared to SPF-1 mice (Figure 2.17 A-C). In line with our 
previous results, S. Typhimurium loads in the contents of SPF-1 mice that 
received the cultured bacteria were similar to the one in SPF-1 mice, while 
pathogen loads in the tissues were reduced (Figure 2.17 D-E). These results 
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demonstrate that the mix of eleven isolated bacteria is able to ameliorate 
Salmonella-induced disease similar to the complex SPF-2 community. 
 
Figure 2.17 - Isolated bacteria derived from SPF-2 fecal content ameliorate S. 
Typhimurium infection. Isolated bacteria from SPF-2 mice were transferred to SPF-1 (SPF-
1 + cult bacteria). As control whole SPF-2 community was transferred by fecal transplantation 
(SPF-1(FT SPF-2)). (A-C) Body weight was recorded during infection (A) and body weight of 
individual mice on day 1 p.i. is shown (B). Survival was measured during infection (C). (D-E) 
Salmonella infected mice were sacrificed 20 hours p.i. and number of S. Typhimurium CFUs 
was determined in luminal content (D) and tissue (E) of small intestine (SI), cecum and colon. 
Dashed line indicates the limit of detection. Results represent n=4-15 mice/group from one 
experiments as mean ± SEM. P values indicated represent a Mann-Whitney U test 
comparison of totals between groups. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 
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2.5 Discussion 
 
It has been firmly established that the intestinal microbiota has a tremendous 
impact on susceptibility to enteric infection and the severity of intestinal 
inflammation (Buffie and Pamer, 2013). But only recently studies have started 
to reveal the identity of individual members of the complex gut communities 
that are responsible for protection of the host against gastrointestinal 
pathogens. Here, we dissected the influence of microbiota composition and 
specific members of the microbiome on the severity of disease induced by S. 
Typhimurium in a mouse model of acute gastrointestinal disease. While in 
mice Salmonella infection causes a disease resembling human typhoid fever 
without gastroenteritis, antibiotic pre-treatment enables colonization of the 
intestine by Salmonella, which subsequently leads to intestinal inflammation 
(Kaiser et al., 2012). This model has been widely used to study the 
contribution of bacterial virulence factors and host immune pathways to 
disease development and more recently to characterize the interplay between 
pathogen, microbiota and the mucosal immune system. 
Specifically, it had been noted that mice from different conventional colonies, 
presumably with altered microbiota composition, differ in severity of intestinal 
pathology (Kaiser et al., 2012). Moreover, treatment with different antibiotics 
was found to cause distinct changes in the microbiome that were associated 
with varying susceptibility to Salmonella induced colitis despite comparable 
luminal colonization (Ferreira et al., 2011). We decided to follow up on these 
observations and took advantage of the striking differences observed in the 
microbiota of genetically highly related wild type mice obtained from different 
vendors, that we propose could serve as a valuable model representing the 
diverse microbiota compositions observed in humans. Indeed, large 
differences in weight loss and mortality that are surrogates for intestinal 
inflammation were readily detectable. To avoid any influence of genetic drifts 
and spontaneously acquired mutation in the investigated mouse lines, which 
have recently hampered researchers in several cases (Kayagaki et al., 2011; 
Vande Walle et al., 2016), we transferred the respective microbiota of 
susceptible and resistant mouse lines into genetically identical recipient mice. 
Infection experiments with such mice eventually confirmed our conclusion that 
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differences in microbiota composition were solely responsible for the altered 
disease severity. Strikingly, the altered disease severity was not associated 
with differences in luminal colonization, but rather with lowered Salmonella 
loads in the small intestinal and cecal tissues. This suggested that differences 
in microbiota composition were indirectly affecting severity of disease, 
potentially by modulating inflammatory responses and thus, Salmonella 
invasion and expansion in the host. At least two virulence strategies are 
involved in causing intestinal inflammation by Salmonella: The classical 
pathway that requires invasion of the intestinal epithelium enabled by 
virulence factors, which are encoded on spi-1, and the alternative pathway 
involves uptake and survival in phagocytic cells and requires virulence factors 
encoded on spi-2 (Kaiser 2011). We could rule out an involvement of the 
alternative pathway underscoring that specific commensals indirectly 
modulate invasion of epithelial cells or pathogen replication in non-phagocytic 
cells that trigger disease. The induced mucosal inflammation between the 
mouse lines was distinct as higher concentrations of the inflammatory marker 
IL-6 were detected in susceptible mice featuring higher Salmonella loads in 
the tissue. Amelioration of disease severity was associated with higher 
concentrations of IFNγ in the tissue. By using IFNγ deficient mice we 
demonstrated that IFNγ was essential for the modulatory effects of the 
protective microbiota (Figure 2.18). Enhancement of IFNγ expression by 
specific members of the protected microbiota might benefit the host via 
previously identified mechanisms such as controlling pathogen loads in the 
intestinal tissue and regulating mucin release by goblet cells (Godinez et al., 
2008; Rhee et al., 2005; Songhet et al., 2011). 
Much attention has recently focused on characterizing the influence of the 
microbiota and specific commensals on regulating development and 
recruitment of distinct subsets of immune cells including innate and adaptive 
lymphocytes (Honda and Littman, 2016; Klose and Artis, 2016). In order to 
identify in which cellular population IFNγ production is modulated in SPF-1 
and SPF-2 mice, we used an IFNγ reporter mouse that allows identification of 
in vivo cytokine producing cells without further manipulations. As previously 
reported we detected IFNγ production in both CD3- (containing both classical 
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NK cells and ILCs) and CD3+ cells (Dougan et al., 2011; Kupz et al., 2013; 
Spits et al., 2016). The frequency of IFNγ producing CD3+CD4+ T cells was 
increased in SPF-2 mice, whereas the abundance of other IFNγ producing 
subsets was not changed. These cells were negative for IL-17 and thus likely 
represent bona fide TH1 cells. Moreover, we noted also enhanced frequencies 
of IL-17-producing TH17 cells in the SI during infection. Induction of TH17 cells 
by SFB contributes to the immune defense against the enteric pathogen 
Citrobacter rodentium (Ivanov et al., 2009). Moreover, SFB have been 
reported to induce IFNγ from CD4+ T cells in SFB-monocolonized mice, 
consequently we considered the possibility that the presence of SFB in SPF-2 
mice may be responsible for the observed phenotype (Gaboriau-Routhiau et 
al., 2009). But, colonization of SPF-1 mice with SFB did not confer protection 
and indicated that other commensals were responsible for enhancing IFNγ 
production from CD4+ T cells (Figure 2.18).  
In order to identify the bacteria responsible for amelioration of Salmonella-
induced diseases we combined several approaches. First, 16S rRNA 
sequencing identified specific, but complex, signatures in the microbiota 
composition at all tested time points. Second, comparison of the phenotype 
and microbiome after pretreatment using streptomycin and ampicillin, 
antibiotics with distinct antimicrobial spectrum, demonstrated that both groups 
of SPF-2 mice were protected but each antibiotic treatment resulted in very 
distinct changes in the microbiome. Specifically, in the case of ampicillin the 
community of SPF-2 mice post-treatment resembled the community observed 
in ampicillin-treated SPF-1 mice, which were susceptible. Combining this 
observation with the notion that induction of T cell differentiation required 
longer periods, we therefore hypothesized that commensal bacteria, which 
were differentially abundant prior to antibiotic treatment, are required for the 
protection against Salmonella infection. We utilized an approach that had 
been used to perform highly parallelized isolation of intestinal bacteria and 
were able to short-term culture a restricted collection of eleven bacteria from 
five families that represented nine novel species as well as a Lactobacillus 
intestinalis and a Bacteroides acidifaciens isolate. Transfer of these bacteria 
into susceptible SPF-1 mice reduced tissue invasion by Salmonella and 
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delayed Salmonella-induced disease comparable to transfer of the total SPF-
2 community. The protective effect of this restricted community is likely 
mediated via priming of the immune system rather than direct interaction with 
Salmonella. While transferred bacteria add up to around 37% of total 16S 
rRNA reads before antibiotic treatment, most of them are lost after 
streptomycin treatment and are further decreasing during Salmonella infection 
(< 3% of total 16S rRNA reads). Another recent study showed that a 33 
member bacterial community derived from human isolates could reduce 
systemic Salmonella colonization independent of direct colonization 
resistance supporting our findings (Martz et al., 2015). The cultured bacteria, 
which were able to transfer the phenotype, included members of the families 
Prevotellaceae, Bacteroides, S24-7 (all belonging to the phylum 
Bacteroidetes), Lactobacillaceae and Lachnospiraceae (both belonging to the 
phylum Firmicutes) (Figure 2.18). While up to now, none of these bacteria 
have been causally linked to modulate severity of Salmonella infection or to 
regulate TH1 responses, representatives from some of theses families have 
been correlated with less severe gastrointestinal infections in humans and 
mice. For instance, the abundance of the genus Prevotella demonstrated a 
negative correlation with potentially pathogenic E. coli/Shigella in a large 
survey study of small children from the developing world (Pop et al., 2014). 
Moreover, presence of Prevotella copri, a human-restricted member of the 
Prevotellaceae family, was enriched in human volunteers, which showed less 
severe diarrhea after voluntarily ingestion of enterotoxigenic Escherichia coli 
infection compared to volunteers with severe diarrhea (Pop et al., 2016). The 
same study also identified that the presence of Bacteroides vulgatus predicts 
resistance against diarrhea while other Bacteroides species were associated 
with severe diarrhea indicating that species and possibly even strain level 
differences contribute to resistance to enteric infection. The family S24-7 
recently proposed as “Candidatus homeothermaceae” (Ormerod et al., 2016) 
or Muribaculum (Lagkouvardos et al., 2016) has been originally identified as 
group “Mouse Intestinal Bacteria” and found to be enriched in 129S1/SvImJ 
mice that were colonized by Salmonella but resistant to colitis (Ferreira et al., 
2011). Additionally, this family is closely related to the Barnesiella family that 
has been strongly associated with protection against infection with 
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Vancomycin-resistant Enterococcus faecalis (Ubeda et al., 2013). However, 
the lack of available isolates has so far precluded functional studies that could 
be highly relevant due to its high abundance in the microbiota of many mouse 
lines and also some humans (Ormerod et al., 2016). Lachnospiraceae, 
previously known as Clostridium XIVa, are known butyrate-producing 
bacteria. It has been demonstrated that they induce regulatory CD4+ T cells, 
but not TH1 cells, in the colon (Atarashi et al., 2011). Currently we do not 
know if and which individual bacteria of the small community are responsible 
for the identified phenotype, but disentangling the possible interactions of the 
individual members of this community through combinatorial testing will be a 
challenging and laborious task as studies have highlighted that production of 
numerous metabolites might be dependent on interaction between bacteria 
(Faith et al., 2014). 
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Our study has provided firm evidence that microbiota composition strongly 
influences severity of Salmonella-induced disease via a previously unknown 
modulation of mucosal IFNγ production. Former studies largely focused on 
identifying commensals that influence Salmonella colonization in the lumen, 
however, our experiments demonstrate that a restricted consortium of 11 
bacteria is sufficient to ameliorate disease in susceptible mice by reducing 
pathogen colonization of the mucosal tissue. In conclusion, our study revealed 
a novel mechanism how the microbiota contributes to amelioration of 
Salmonella infection via microbiota-induced priming of a protective 
antibacterial response by the mucosal immune system. 
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Identifying microbial signatures associated with reduced 
susceptibility to Citrobacter rodentium infection 
 
3.1 Summary 
 
Infectious diarrhea, induced by foodborne pathogens, is a significant health 
problem worldwide. Upon oral uptake, pathogens encounter in the 
gastrointestinal tract a diverse community of commensal bacteria, collectively 
termed the microbiota. An undisturbed microbiota greatly reduces the 
chances of a successful colonization by the invading enteric pathogens. But, 
an imbalanced community may lead to dysregulation of the intestinal 
homeostasis and, in turn, facilitate colonization and inflammation of enteric 
pathogens. Specific interactions between distinct groups of commensals and 
pathogens are hypothesized to determine an individual’s susceptibility to 
infection. However, the contributions of individual members of the microbiota 
are largely unknown.  
Here, we demonstrate that C57BL/6N mouse lines from different breeding 
facilities display highly varying susceptibility to infection with the pathogen 
Citrobacter rodentium, a mouse model for human enterohemorrhagic 
Escherichia coli (EHEC) and enteropathogenic E. coli (EPEC). Using 16S 
rRNA sequencing, we identified a microbial signature associated with reduced 
pathogenic colonization. By using cohousing experiments with susceptible 
and resistant mouse lines, bacteria of the family Lachnospiraceae were highly 
linked to amelioration to C. rodentium induced disease. Identifying intestinal 
bacteria, which enhance protection against enteric infections, is crucial for the 
development of novel mucosal therapies. 
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3.2 Introduction 
 
The gastrointestinal tract (GI) is colonized by a complex bacterial community, 
which has a large impact on the host immune system playing an essential role 
in health and disease. One major task of the microbiota is to protect the host 
against invading pathogens via a process called colonization resistance 
(Buffie and Pamer, 2013). Colonization resistance is realized via direct 
microbiota-pathogen interactions (e.g. competition for essential nutrients, 
production of toxic compounds, occupancy of niches), but also indirectly via 
immune-mediated mechanisms through the induction of immune cells that 
target enteric pathogens. Environmental factors such as antibiotic treatment 
affect strongly the composition of the intestinal microbiota, leading to severe 
dysregulation of the intestinal homeostasis. For instance, altered gut 
composition induced by antibiotic treatment can influences colonization of 
invading enteric pathogens (Bohnhoff and Miller, 1962; Sekirov et al., 2008).  
Moreover, composition of the microbiota greatly varies among individuals, 
possibly explaining different susceptibilities to enteric infections (Human 
Microbiome Project Consortium, 2012).  
Infectious diarrhea, especially caused by enteric pathogens, is a major health 
problem worldwide, contributing significantly to morbidity and mortality (WHO, 
2013). In particular, the foodborne pathogens enterohemorrhagic Escherichia 
coli (EHEC) and enteropathogenic E. coli (EPEC) can cause a severe 
infection characterized by GI inflammation and in some cases life-threatening 
diarrhea (Collins et al., 2014).  
The mouse-restricted pathogen C. rodentium is closely related to the clinically 
important human pathogens EHEC and EPEC, also belonging to the 
pathogenic family of A/E lesion-forming bacteria (Petty et al., 2010). Highly 
similar to EHEC and EPEC, attaching C. rodentium efface the microvilli and 
induce cytoskeletal changes such as accumulation of polymerized actin, 
forming distinct pedestal-like structure beneath the site of attachment. Genes 
important for formation of A/E lesions are encompassed within a 35 kb 
pathogenicity island known as the locus of enterocyte effacement (LEE), 
encoding the type III secretion system (T3SS) (Deng et al., 2004). Via the 
T3SS effector proteins are translocated into the host cell cytoplasm. One 
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essential and well studied virulence factor important for inducing inflammation 
of C. rodentium is the translocated intimin receptor (Tir), similar to Tir 
expressed in EHEC and EPEC (Deng et al., 2003). During the attachment to 
gut enterocytes, C. rodentium does not bind to a host receptor, but instead 
translocate its own receptor Tir into the cytoplasm of host cell. After 
translocation Tir is displayed on the surface of enterocytes, to which the outer-
membrane bacterial protein intimin binds, triggering host signaling events 
(Deng et al., 2003; Kenny et al., 1997). Colonization of C. rodentium leads to 
infectious colitis characterized histologically by immune cell infiltration, 
intestinal crypt elongation and depletion of goblet cells (Bhinder et al., 2013). 
Since EHEC and EPEC are mainly human pathogens, which induce only 
modest pathogenicity in mice, C. rodentium is a valuable and frequently used 
mouse model for these infections (Mundy et al., 2005).  
In last years, several studies highlighted the large effect of the microbiota 
composition on the intestinal colonization of C. rodentium. For instance, 
antibiotic treatment with metronidazole has been shown to disrupt the 
microbiota composition, increasing susceptibility to C. rodentium infection due 
to an altered goblet cell function (Wlodarska et al., 2011). Strikingly, in the 
same study antibiotic treatment with streptomycin has been shown to alter the 
composition of the microbiota, but do not affect severity of infection 
(Wlodarska et al., 2011). Therefore, this study implicated that specific, still 
unknown bacteria are responsible for protection rather than the decrease in 
diversity, which is induced upon antibiotic treatment. Additionally, successful 
fecal transplantation from resistant to susceptible mice to C. rodentium-
induced colitis suggests the importance of the microbiota to protect the host 
against enteric pathogens (Willing et al., 2011). Interestingly, fecal 
transplantation increased interleukin (IL)-22-mediated defense coupled with 
augmented antimicrobial peptides regenerating islet-derived 3 (Reg3)γ and 
Reg3β, which decreased susceptibility to infection (Willing et al., 2011).  This 
study indicated how yet unknown bacteria promote resistance indirectly, by 
enhancing immune-mediated protection to C. rodentium infection. In addition, 
changing the diet of the host has been shown to promote higher abundance of 
Clostridia species, which were associated to influence the epithelial barrier, 
therefore, indirectly affecting luminal colonization of C. rodentium (Wlodarska 
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et al., 2015).  Also direct mechanisms of commensal bacteria have been 
identified to target C. rodentium colonization. During infection, expansion of 
commensal E. coli inhibits C. rodentium colonization via competing for 
monosaccharides as nutrient (Kamada et al., 2012).   
Although, it is known that the intestinal microbiota affects the susceptibility to 
infections of C. rodentium, research is still in its infancy and little is know 
which specific commensal bacteria and which pathogen-microbiota 
interactions contribute to protection against colonization of C. rodentium.  
In this study, we could demonstrate that isogenic C57BL/6N mice from 
different breeding facilities feature distinct microbiota compositions, which 
also differ in their susceptibility to C. rodentium infection. Correlation analysis 
including cohousing experiments with susceptible and resistant mice could 
reveal that two bacteria from the family Lachnospiraceae are associated with 
lower luminal colonization of C. rodentium. Detailed understanding how 
commensal bacteria interact with the pathogen and the host to confer 
resistance is important for the development of therapies to manipulate the 
microbiota against infections.  
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3.3 Methods 
3.3.1 Mice  
 
C57BL/6N SPF-1 mice were purchased from NCI and maintained (including 
breeding and housing) at the animal facilities of the Helmholtz Centre for 
Infection Research (HZI) under enhanced specific pathogen-free (SPF) 
conditions. C57BL/6N SPF-2, SPF-3, SPF-4, SPF-6 and SPF-7 mice were 
purchased from different vendors and housed under enhanced SPF 
conditions at the HZI for at least two weeks before the start of the experiment: 
Charles River (SPF-2 and SPF-3), Harlan (SPF-4), Janvier (SPF-6), and 
Taconic (SPF-7). SPF-5 mice were generated, bred and housed under 
enhanced SPF conditions at the HZI (Stehr et al., 2009). Germ-free 
C57BL/6NTac mice were bred in isolators (Getinge) in the germ-free facility at 
the HZI.  
Animals used in experiments were gender and age matched. Mice with an 
age of 8-12 weeks were used. Mice were provided with sterilized food and 
water ad libitum. Mice were kept under strict 12-hour light cycle (lights on at 
7:00 am and off at 7:00 pm) and housed in groups of up to 6 mice per cage. 
All mice were euthanized by asphyxiation with CO2 and cervical dislocation. 
Both female and male mice were used in experiments. All animal experiments 
have been performed in agreement with the local government of Lower 
Saxony, Germany (approved permission No. 33.4-42502-04-14/1415). 
3.3.2 Microbiota manipulation 
 
For cohousing experiments with conventional raised mice, age- and gender-
matched C57BL/6N mice were housed together in cages at 1:1 ratios for at 
least four weeks before infection experiments. For cohousing experiments 
with germ-free mice, mice were cohoused at 1:1 ratio in specific ventilated 
isocages equipped with individual HEPA filters (Tecniplast).  
3.3.3 C. rodentium infection 
 
Bioluminescence expressing C. rodentium strain ICC180 was used for all 
infection experiments (Wiles et al., 2004). C. rodentium inoculums were 
prepared by culturing bacteria overnight at 37°C in LB broth with 50 µg/ml 
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kanamycin. Subsequently, the culture was diluted 1:100 in fresh medium, and 
subcultured for 4 hours at 37°C in LB broth. Bacteria were washed twice in 
ice-cold phosphate-buffered saline (PBS). Mice were orally inoculated with 
107 CFU of C. rodentium diluted in 200 µl PBS. Weight of the mice was 
monitored and feces were collected every second day after infection for 
measuring pathogen burden and 16S rRNA sequencing. 
3.3.4 Quantification of fecal C. rodentium colonization 
 
Fresh fecal samples were collected and weight was recorded. Subsequently, 
fecal samples were homogenized in 1 ml LB media by bead-beating with 1mm 
zirconia/silica beads. Two samples were homogenized for 25 sec using a 
Mini-Beadbeater-96 (BioSpec). To determine CFUs, serial dilutions of 
homogenized samples were plated on LB and MacConkey plates, if 
necessary 50 µg/ml Kanamycin was added to media. Plates were cultured at 
37°C for 1 day before counting. CFUs of C. rodentium were calculated after 
normalization to the weight of feces.  
3.3.5 DNA isolation and library preparation 
 
DNA was extracted using a phenol-chloroform method as describe previously 
(Turnbaugh et al., 2009). Briefly, extraction buffer (200 mM Tris, 20 mM 
EDTA, 200 mM NaCl, pH 8.0), 200µl of 20% SDS and 500 µl of 
phenol:chloroform:isoamyl alcohol (24:24:1) was added to frozen samples. To 
lyse bacterial cells, mechanical disruption method was chosen using 0.1-mm 
diameter zirconia/silica beads and Mini-BeadBeater-96 (BioSpec). For lysis, 
samples were homogenized twice for 2 min. After centrifugation, aqueous 
phase was passed for another phenol:chloroform:isoamyl alcohol extraction. 
Furthermore, 0.1 volume of 3 M sodium acetate and an equal volume of ice-
cold isopropanol were added to precipitate DNA. Samples were incubated at -
20°C for at least 1 hour and then centrifuged at 4°C at maximum speed for 20 
min. Resultant pellet was washed with 75% ethanol and dried by using speed 
vacuum for 15 min. Crude DNA pellets were resuspended in TE buffer with 
100 µg/ml RNAse and subsequently, purified by column purification 
(BioBasic). To perform 16S rRNA gene amplification of V4 16S rRNA region, 
crude DNA was normalized to 25 ng/µl. A unique 12-base Golary barcode to 
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each sample was incorporated via specific primers for identification (Caporaso 
et al., 2011). PCR was performed in triplicates and pooled afterwards. 
Genomic DNA was quantified by using PicoGreen dsDNA quantitation kit 
(Invitrogen) and normalized to 10 nM DNA. Samples were pooled and 
quantified by using KAPA Library Quantify Kit SYBR (Kapa Biosystems).  
3.3.6 16S rRNA analysis 
 
Amplification of the V4 region (F515/R806) of the 16S rRNA gene was 
performed according to previously described protocols (Caporaso et al., 
2011). Samples were sequenced on an Illuminia MiSeq platform via 250 bp 
paired-end sequencing. Sequences were filtered for low quality reads and 
binned based on sample-specific barcodes using QIIME v1.8.0 (Caporaso et 
al., 2010). Quality filtering was set up to -q 30, minimum read length 200 bp 
and minimum number of sequences per sample = 1000. Reads were 
clustered into 97% ID OTUs using open-reference OTU picking with UCLUST 
(Edgar, 2010), followed by abundance filtering (OTUs cluster > 0.5%) and 
taxonomic classification using the RDP Classifier executed at 80% bootstrap 
confidence cut off (Wang et al., 2007). Sequences without matching reference 
dataset, were grouped as de novo using UCLUST. Phylogenetic relationships 
between OTUs are determined using FastTree to the PyNAST alignment 
(Price et al., 2010). The OTU absolute abundance table and mapping file are 
used for statistical analyses and data visualization in the R statistical 
programming environment package phyloseq (McMurdie and Holmes, 2013).  
The phylogenetic tree was created using the Neighbor-Joining method (Saitou 
and Nei, 1987). The percentage of replicate trees in which the associated taxa 
clustered together in the bootstrap test (10000 replicates) is shown next to the 
branches (Zharkikh and Li, 1995). The evolutionary distances were computed 
using the Maximum Composite Likelihood method (Tamura et al., 2004). 
Evolutionary analyses were conducted in MEGA6 (Tamura et al., 2013). 
3.3.7 Statistical analysis 
 
Statistical analysis was performed using GraphPad Prism v6.0. Differences 
were analyzed by Student’s t test and one-way ANOVA.  
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P values indicated were calculated by a non-parametric Mann-Whitney U test 
or Kruskal-Wallis test comparison of totals between groups. 
Linear discriminant analysis (LDA) effect size (LEfSe) method was used to 
identify bacterial OTUs that explained differences between microbiota 
compositions (Segata et al., 2011). OTUs with Kruskal-Wallis test <0.05 and 
LDA scores >3.0 were considered for analysis.   
P values lower than 0.05 were considered as significant: *p<0.05, **p<0.01, 
***p<0.001, ****p<0.0001 
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3.4 Results  
3.4.1 Isogenic mouse lines from different breeding facilities reveal 
distinct microbiota compositions 
 
In order to identify bacteria linked to resistance against C. rodentium infection, 
we evaluated isogenic mouse lines regarding potential differences in 
microbiota composition that could reflect the diverse microbiome in humans. 
To this end, we first screened the microbiota of age- and gender-matched 
C57BL/6N specific pathogen free mice (SPF) from different breeding facilities 
and barriers (SPF-1 – SPF-7). Mice were housed in our vivarium for at least 
10 days to adjust for housing conditions (diet, water, bedding). To analyze the 
composition of the microbiota, 16S rRNA analysis of the fecal microbiota was 
performed. Analysis of β-diversity revealed differences in the microbiota of 
each breeding facility (Figure 3.1 A).   
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Figure 3.1 - Isogenic mouse lines feature distinct microbiota compositions. Fecal 
microbiota of different specific pathogen free (SPF) mouse lines including SPF-1 (n=17), 
SPF-2 (n=18), SPF-3 (n=7), SPF-4 (n=9), SPF-5 (n=15), SPF-6 (n=4) and SPF-7 (n=12) 
were evaluated using 16S rRNA sequencing. (A) β-diversity was analyzed using Bray-Curtis 
dissimilarity matrix and PCoA plot. (B) α-diversity was determined using Chao1 and Shannon 
index. (C) Relative abundance at phylum level for each group is shown. (D) Ratio of 
taxonomic order Firmicutes and Bacteroidetes for each group. Representative data derived 
from one experiment (SPF-4, SPF-6) or are pooled from at least two different experiments 
(SPF-1, SPF-2, SPF-3, SPF-5, SPF-7). P values indicated represent a nonparametric 
Kruskal-Wallis test with multiple comparisons (one-way ANOVA). *p<0.05, **p<0.01, 
***p<0.001, ****p<0.0001.  
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Samples clustered largely according to mouse line. Specifically, mouse lines 
from different breeding facilities harbored a distinct composition, whereas the 
mouse lines from the same vendor but different barriers (SPF-2 and SPF-3) 
had a similar microbial composition.  
 
Next, α-diversity (species diversity within the community of each sample) was 
analyzed by using Chao1 (species richness) and Shannon indices (species 
richness combined with abundance) between the isogenic mouse lines 
(Figure 3.1 B). All mouse lines harbored a complex microbiota, but the 
microbial diversity varied between the groups. The microbiota of SPF-1 and 
SPF-4 mice showed a significantly lower α-diversity than the microbiota of 
SPF-2, SPF-3, SPF-5, SPF-6 and SPF-7 mice.  
Figure 3.2 - Mice from different vendors reveal differences in their microbiota 
composition at taxonomical level of family. Fecal microbiota of different specific pathogen 
free (SPF) mouse lines including SPF-1 (n=17), SPF-2 (n=18), SPF-3 (n=7), SPF-4 (n=9), 
SPF-5 (n=15), SPF-6 (n=4) and SPF-7 (n=12) was analyzed using 16S rRNA sequencing. 
Relative abundances of bacterial families are shown and grouped according to their phylum. 
Bars represent the mean of all mice within the group. Representative data are from one 
experiment (SPF-4, SPF-6) or pooled from at least two different experiments (SPF-1, SPF-2, 
SPF-3, SPF-5, SPF-7). 
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In addition, microbial composition was analyzed at different taxonomic levels 
(phylum, family, genus/OTU). Analysis of the relative abundances of bacterial 
phyla identified differences already at this level affecting the phyla 
Bacteroides, Firmicutes, Proteobacteria and Verrucomicrobia (Figure 3.1 C). 
In particular, ratio of Firmicutes to Bacteroides level is highly increased in 
SPF-5 mice, whereas the other microbiota settings reveal a higher abundance 
of Bacteroidetes (Figure 3.1 D).  
Analysis of lower taxonomical level (family and OTU level) discovered large 
microbial differences in the bacterial families of Bacteroidaceae (i.e. high in 
SPF-1; absent in SPF-5 and SPF-7), Prevotellaceae (i.e. high abundant in 
SPF2 and SPF-3; absent in SPF-5), S24-7 (i.e. high abundant in SPF-6; 
absent in SPF-5), Desulfovibrionaceae (i.e. high in SPF2 and SPF-3; absent 
in SPF-5, SPF-6 and SPF-7), Verrucomicrobiaceae (i.e. high abundant in 
SPF-1; absent in SPF-5) (Figure 3.2 and 3.3). 
 
Figure 3.3 - Mice from different vendors display distinct microbiota composition at 
OTU level. Fecal microbiota of different specific pathogen free (SPF) mouse lines including 
SPF-1 (n=17), SPF-2 (n=18), SPF-3 (n=7), SPF-4 (n=9), SPF-5 (n=15), SPF-6 (n=4) and 
SPF-7 (n=12) was analyzed using 16S rRNA sequencing. Heatmap of relative abundances of 
bacterial OTUs (≥97% sequence similarity, >0.05% relative abundance) is sorted by family, 
class and order as well as mouse line. Each vertical bar represents the microbiota of an 
individual mouse. Representative data are from one experiment (SPF-4, SPF-6) or pooled 
from at least two different experiments (SPF-1, SPF-2, SPF-3, SPF-5, SPF-7). 
In summary, by analyzing mice from different breeding facilities, we identified 
unique microbial signatures in the fecal microbiota of examined isogenic 
mouse lines. Differences were observed at all taxonomical level from phylum 
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to OTU level. Notably, mice derived from different barriers, but same breeding 
facility, revealed higher similarity in their microbial signature.  
 
3.4.2 Isogenic mouse lines feature different susceptibilities to C. roden-
tium infection 
 
Since isogenic mice from different breeding facilities harbor distinct microbial 
communities in their intestine, we hypothesized that they display distinct 
disease progressions when infected with C. rodentium. In order to test this 
hypothesis, age- and gender-matched SPF-1 – SPF-7 mice were infected with 
107 CFU C. rodentium by oral gavage (Figure 3.4 A). 
 
Figure 3.4 - Isogenic mouse lines differ in their susceptibility to C. rodentium infection. 
(A) Mice with different microbiota settings (SPF-1-SPF-7) were infected orally with 107 CFU 
Citrobacter rodentium (C. rod). (B) CFU of C. rod was determined in the feces of each mouse 
line at baseline before infection (BSL) and day 1, 3, 5, 9 and 14 post infection (p.i.). (C) Fecal 
samples were cultured on MacConkey agar during infection. Lactose-fermenting (Lac+) 
colonies represent Escherichia coli. (D) Body weight was recorded during the course of 
infection. Dashed lines indicate the limit of detection. Results represent n=4-18 mice/group as 
mean ± SEM from one experiment (SPF-4, SPF-6) or pooled from at least two different 
experiments (SPF-1, SPF-2, SPF-3, SPF-5, SPF-7).  
 
Colonization of C. rodentium in feces was monitored longitudinally during 
infection and kinetic of C. rodentium colonization was noted to be significantly 
different between mouse lines (Figure 3.4 B and 3.5). 
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In the first days after infection (day 1 and 3 p.i.), SPF-1 mice showed the 
highest pathogen burden in stool, whereas SPF-2, SPF-3, and SPF-7 mice 
had the lowest colonization. In contrast, SPF-4, SPF-5, and SPF-6 displayed 
an intermediate susceptibility at day 1 p.i (Figure 3.5). Clearance of of C. 
rodentium is delayed in SPF-2 mice, which showed a significantly higher 
colonization as seen in SPF-1 and SPF-4 mice at later analyzed time points 
(day 14 p.i.).  
It has been reported that gut inflammation favors the outgrowth of 
Enterobacteriaceae from within the host intrinsic commensal microbiota and 
that they may act as competitors of invading pathogens (e.g. commensal E. 
coli during S. Typhimurium infection) (Lupp et al., 2007; Stecher et al., 2007). 
Therefore, we quantified the level of Enterobacteriaceae before and during 
infection by culturing stool on MacConkey agar plates (selective for Gram-
negative enteric bacteria). Lactose-utilizing (Lac+) colonies were detected at 
low numbers only in SPF-6 mice, but disappeared during infection (Figure 3.4 
Figure 3.5 - Colonization kinetics during C. rodentium differs in isogenic mouse lines. 
C. rodentium CFUs in feces of individual mice of each mouse line are displayed on day 1, 3, 
5, 9 and 14 post infection (p.i.). Dashed lines indicate the limit of detection. Results represent 
n=4-18 mice/group as mean ± SEM from one experiment (SPF-4, SPF-6) or pooled from at 
least two different experiments (SPF-1, SPF-2, SPF-3, SPF-5, SPF-7). P values indicated 
represent a nonparametric Kruskal-Wallis test with multiple comparisons (one-way ANOVA). 
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.  
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C). Lac+ colonies were isolated and their 16S rRNA gene was sequenced 
using Sanger sequencing identifying them as E. coli. In addition, C. rodentium 
is a delayed lactose fermenter and colonies could be distinguished by the 
appearance of a red center and colorless margin (Fox, 2007). CFUs of C. 
rodentium plated on MacConkey are identically with CFUs plated on LB agar 
added with kanamycin displayed in Figure 3.4 B (data not shown). 
SPF-6 is the only mouse line, which harbor other Lac+ colonies than C. 
rodentium, identified as E. coli. Differently than reported during Salmonella 
infection (Stecher et al., 2013), enterobacterial bloom of E. coli was absent 
and E. coli disappeared in SPF-6 mice in the course of C. rodentium infection. 
Therefore, it is likely that E. coli is indispensable for resistance against C. 
rodentium infection.   
In order to monitor severity of gastroenteritis, body weight was measured 
during infection. Severe body weight loss during disease was absent in all 
mouse lines (< 5% of weight loss). Moreover, no significantly differences in 
weight loss between mouse lines was observed (Figure 3.4 D).  
Changes in the intestinal microbiota were analyzed by 16S rRNA analysis at 
different time points (before infection, day 1, 3, 5, 9, 14 p.i.) (Figure 3.6 A-E). 
Due to larger samples number per group, mouse lines with higher (SPF-1) 
and lower susceptibility (SPF-2, SPF-3, SPF-7) were selected.  
In order to identify the microbial dynamic during infection, changes in the fecal 
microbiota was analyzed at different time points of the infection (before 
infection, day 1, 3, 5, 9 and 14 p.i.). As represented in a PCoA plot, microbial 
changes during different phases of infection are minor compared to the 
differences observed between mouse lines (Figure 3.6 A). In addition, relative 
abundances of bacterial families were examined for each microbiota setting 
during infection. At early time points of infection, microbial composition was 
relatively stable, whereas during course of disease differences in the bacterial 
abundances could be observed (Figure 3.6 B-E). In particular, SPF-7 mice 
displayed a high microbial dynamic, i.e. higher abundance of unclassified 
bacteria (indicated as “Others”) as well bacteria of the family Lachnospiraceae 
and Ruminococcaceae than before infection (Figure 3.6 E).  
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In contrast, only small changes in the bacterial community during infection 
were observed in SPF-2 mice (Figure 3.6 C). Changes of the microbiota in 
SPF-1 and SPF-3 mice were low during infection and could be explained by 
altered bacterial abundances (Figure 3.6 A, 3.6 C). Besides in SPF-7 mice, 
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Figure 3.6 - Intestinal microbiota during different phases of C. rodentium infection. 
SPF-1 (n=17), SPF-2 (n=18), SPF-3 (n=7) and SPF-7 (n=12) were infected orally with C. 
rodentium and fecal microbiota was analyzed using 16S rRNA sequencing before infection, 
day 1, 3, 5, 9 and 14 post infection (p.i.). (A) β-diversity was analyzed using Bray-Curtis 
dissimilarity matrix and PCoA plot. (B-E) Relative abundances of bacterial families are shown 
before and during C. rodentium infection for each group, SPF-1 (B), SPF-2 (C), SPF-3 (D) 
and SPF-7 (E). Bars represent the mean of all mice within the group. Data are pooled from at 
least two different experiments.  
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the microbiota of SPF-1, SPF-2 and SPF-3 mice do not show a significant 
outgrowth of a bacterial family, which could explain the resistance or 
susceptible phenotype.  
To exclude that differences in the genotype between C57BL6/N sub-lines are 
responsible for the observed phenotype, we cohoused SPF-1 and SPF-2 mice 
with germ-free C57BL6/NTac mice for at least four weeks (Figure 3.7 A). 
Analyzing the microbiota by 16S rRNA sequencing after cohousing confirmed 
that recipient formerly GF mice feature the same microbiota composition in 
feces as respective donor mice (SPF-1, SPF-2) (Figure 3.7 B). Strikingly, 
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Figure 3.7 - Differences in disease severity are microbiota-dependent. (A) C57BL6/N 
germ-free mice (GF) were cohoused with SPF-1 and SPF-2 mice for 4 weeks and infected 
with C. rodentium (C. rod). (B) Fecal microbiota was analyzed using 16S rRNA sequencing 
before infection, day 1, 3, 5, 9 and 14 post infection (p.i.). β-diversity was analyzed using 
Bray-Curtis dissimilarity matrix and PCoA plot. (C) C. rodentium CFUs in feces of individual 
mice of each mouse line are displayed on day 1, 3, 5, 9 and 14 p.i. Dashed lines indicate the 
limit of detection. Results represent one independent experiment with n=5-9 mice/group as 
mean ± SEM. P values indicated represent a Mann-Whitney U test comparison between 
group exGF(SPF-1) and exGF(SPF-2) as well as SPF-1 and SPF-2. *p<0.05, **p<0.01, 
***p<0.001, ****p<0.0001 
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recipient GF mice show a similar degree of C. rodentium colonization as the 
respective SPF-1 or SPF-2 donor mice (Figure 3.7 C). The results show that 
the observed phenotype fully depends on the microbiota composition.  
In summary, the results strongly suggest that isogenic C57BL/N mice differ in 
their kinetics of C. rodentium colonization and clearance. Cohousing 
experiments with germ-free mice indicate that colonization kinetics were truly 
influenced by the microbiota composition.  
 
3.4.3 In isogenic mouse lines distinct bacteria are linked to resistance 
and susceptibility to C. rodentium infection  
 
We hypothesized that the presence of specific bacteria is linked to higher or 
lower colonization at early time points of infection (resistant/susceptible). To 
identify potentially microbial biomarkers correlated with lower and higher C. 
rodentium colonization, the linear discriminant analysis (LDA) effect size 
(LEfSe) method, coupled with standard tests for statistical significance was 
used (Segata et al., 2011). The LEfSe algorithm contains different steps to 
detect differentially abundant bacteria. First, non-parametric factorial Kruskal-
Wallis sum-rank test was implemented to identify bacteria with significant 
differential abundance with respect to class of interest (susceptibility). 
Subsequently, biologically consistency was determined among subclasses 
(mice from different breeding facilities) using the unpaired Wilcoxon rank-sum 
test. Afterwards, effect size of each differentially abundant bacterium was 
evaluated, ranked according to the effect size and displayed in a histogram. 
Analysis was focused on the microbiota composition at steady state in SPF-1 
mice with the highest susceptibility and compared with SPF-2, SPF-3 and 
SPF-7 mice, showing the lowest susceptibility to C. rodentium at early time 
points. The most enriched bacterial taxa in susceptible mice belong to the 
family: Verrucomicrobiaceae, Bacteroidaceae and Alcaligenaceae (Figure 3.8 
A-B). Specifically, bacteria of the family Bacteroidaceae are lower abundant in 
all microbiota settings linked to resistance (Figure 3.9 A). Alcaligenaceae are 
absent in microbiota settings linked to resistance (SPF-2, SPF-3, SPF-7) and 
only detectable in most of the SPF-1 mice (Figure 3.9 B). 
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Figure 3.8 - Microbial signatures associated with reduced disease susceptibility of C. 
rodentium. Statistically significant bacterial differences in the fecal microbiota between 
susceptible (SPF-1) and resistant (SPF-2, SPF-3 and SPF-7) mice before treatment was 
analyzed at family level using LEfSe (Kruskal-Wallis and pairwise Wilcoxon test p<0.05, LDA 
>3.0). Data are displayed as cladogramm (A) and bars (B) ranking them accordingly to the 
effect size and associating them to their degree of susceptibility. Data are pooled from at least 
two different experiments with n=7-18 mice/group.  
 
 
Figure 3.9 - Individual biomarkers associated with higher susceptibility. Statistically 
significant differences of microbial signatures linked to a higher degree of susceptibility are 
displayed of individual mice (SPF-1, SPF-2, SPF-3, SPF-7) on family level before infection: 
(A) Bacteroidaceae, (B) Alcaligenaceae, (C) Verrucomicobiaceae. Results represent n=8-18 
mice/group as mean ± SEM pooled from at least two different experiments. 
 
Bacteria of the family Verrucomicrobiaceae are also absent in most of SPF-2 
and SPF-3 mice, while some SPF-7 mice harbour Verrucomicrobiaceae, but 
in lower relative abundances than in SPF-1 mice (Figure 3.9 C). In contrast, 
bacteria of the family Prevotellaceae, S24-7, Ruminococcaceae and 
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unclassified bacteria of the order Clostridales are enriched in mice with lower 
susceptibility (Figure 3.8 A-B). Bacteria of the family Prevotellaceae, 
Ruminococcaceae and the order Clostridales spp. are absent or lower 
abundant in SPF-1 mice compared to SPF-2, SPF-3 and SPF-7 mice (Figure 
3.10 A, 3.10 C-D). In contrast, bacteria of the family S24-7 are present in low 
as well as high abundance in SPF-1 mice and only a small statistically 
difference exists between susceptible SPF-1 mice and resistant SPF-2, SPF-3 
and SPF-7 mice.  
 
 
Figure 3.10 - Individual biomarkers associated with higher resistance. Statistically 
significant differences of microbial signatures linked to higher resistance are displayed of 
individual mice (SPF-1, SPF-2, SPF-3, SPF-7) on family level before infection: (A) 
Prevotellaceae, (B) S24-7, (C) Ruminococcaceae, (D) Clostridia spp. Results represent n=8-
18 mice/group as mean ± SEM pooled from at least two different experiments. 
 
By using comparative analysis coupled with different microbiota settings and 
statistically tests, microbial signatures associated with susceptibility and 
resistance to C. rodentium colonization at early time points were identified. 
Presence of bacteria of the families Verrucomicrobiaceae, Bacteroidaceae 
and Alcaligenaceae were associated with higher susceptibility, whereas 
bacteria of the family Prevotellaceae, S24-7, Ruminococcaceae and 
unclassified bacteria of the order Clostridales were linked to higher resistance.  
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3.4.4 Cohousing experiments reveal bacterial biomarkers responsible 
for resistance against C. rodentium 
 
To identify if bacteria linked to susceptibility or resistance can be transferred 
and alter susceptibility, SPF-1 (susceptible) and SPF-2 (resistant) mice were 
cohoused for 4 weeks and mice were infected with 107 CFU C. rodentium by 
oral gavage (Figure 3.11 A).  
 
Figure 11 - Altered susceptibility to C. rodentium infection upon cohousing of SPF-1 
and SPF-2 mice. (A) SPF-1 and SPF-2 mice were cohoused for 4 weeks and infected with C. 
rodentium (C. rod). (B) Fecal microbiota was analyzed using 16S rRNA sequencing before 
and after cohousing as well as during infection, day 1, 3, 5 and 9 post infection (p.i.). β-
diversity was analyzed using Bray-Curtis dissimilarity matrix and PCoA plot. (C-D) C. 
rodentium CFUs in feces of individual mice of SPF-1 cohoused (coh) with SPF-2 mice (C) 
and SPF-2 mice coh with SPF-1 (D) are displayed on day 1, 3, 5, 9 and 14 p.i. Dashed lines 
indicate the limit of detection. Results represent one independent experiment with n=8-10 
mice/group. 
Upon cohousing, fecal microbiota of SPF-1 and SPF-2 mice showed a distinct 
and diverse microbial community, at steady state (after cohousing) and during 
C. rodentium infection. Most of the mice display a mixed community of the 
original SPF-1 and SPF-2 microbiota (Figure 3.11 B). Interestingly, when 
SPF-1 mice cohoused with SPF-2 mice (SPF-1 coh SPF-2) are infected with 
C. rodentium, around half of the mice displayed lower CFU numbers at early 
time points of infection (1d, 3d, 5d p.i.), indicating a higher resistance (Figure 
3.11 C). Whereas the other SPF-1 coh SPF-2 mice phenocopy the SPF-1 
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phenotype (non-cohoused). Notably, also some SPF-2 mice cohoused with 
SPF-1 mice (SPF-2 coh SPF-1) showed an altered susceptibility. As seen in 
SPF-1 coh SPF-2, around half of the SPF-2 coh SPF-1 mice were 
characterized by enhanced susceptibility, whereas the other half mimics a 
non-cohoused SPF-2 phenotype (Figure 3.11 D). Color-coding of resistant 
and susceptible mice upon infection in afore analyzed PCoA plot (Figure 3.11 
B) did not identify distinct microbial communities in resistant and susceptible 
mice (Figure 3.12 A).  
Figure 3.12 - Microbial signature associated with higher resistance after cohousing. 
SPF-1 and SPF-2 mice were cohoused for 4 weeks and infected with C. rodentium. Fecal 
microbiota was analyzed using 16S rRNA sequencing before and after cohousing as well as 
during infection, day 1, 3, 5 and 9 post infection (p.i.) (data see Figure 11). (A) β-diversity was 
analyzed using Bray-Curtis dissimilarity matrix and PCoA plot ordered regarding their 
susceptibility to C. rodentium infection. (B) Statistically significant differences in the fecal 
microbiota between susceptible and resistant mice before treatment was analyzed on OTU 
level using LEfSe (Kruskal-Wallis test p<0.05, LDA 3.0), ranking them accordingly to their 
effect size. Results represent one independent experiment with n=8-10 mice/group. 
Using LEfSe analysis on OTU level at steady state revealed that specific 
bacteria of the order Clostridales (Eubacteriaceae spp., Lachnospiraceae spp. 
1, Lachnospiraceae spp. 2, Clostridales spp. 3) and of the order Bacteroidales 
(Rikenellaceae spp.) are linked to resistance (Figure 3.12 B). No bacteria 
were found to be associated with increased susceptibility. Abundances of 
statistically different bacteria associated with resistance are displayed per 
individual mice sorted according to their colonization on 1d p.i. (Figure 3.13).  
Moreover, relative abundances of statistically different OTUs linked to 
resistance in cohouse mice were analyzed in SPF-1 and SPF-2 mice at 
steady state (Figure 3.14). Notably, Rikanellaceae spp. and Lachnospiraceae 
spp. 3 were not associated with resistance (SPF-2), although displayed higher 
abundance in susceptible mice (SPF-1). However, Lachnospiraceae spp. 1 
and Lachnospiraceae spp. 2 were absent in susceptible SPF-1 mice and 
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abundant in resistant SPF-2 mice, similar what was seen in cohousing 
experiments. Therefore, Lachnospiraceae spp. 1 and Lachnospiraceae spp. 2 
are valuable bacterial candidates linked to resistance.  
Figure 3.13 - Individual biomarkers linked to higher resistance in cohoused mice. 
Statistically significant different bacteria between resistant and susceptible mice associated 
with ameliorated disease are displayed of individual mice before infection and ordered 
regarding their susceptibility. Results represent n=8-10 mice/group as mean ± SEM from one 
independent experiment. 
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Figure 3.14 - Abundance of identified biomarkers in SPF-1 and SPF-2 mice. Identified 
bacteria linked to higher resistance were analyzed in SPF-1 and SPF-2 before and during 
infection on OTU level. Results represent n=5-6 mice/group from one independent 
experiment. 
            3 | CHAPTER 
 
- 117 - 
 
 
Moreover, full-length 16S rRNA sequences of the two bacterial candidates 
associated with resistance were reassembled by using database of de novo 
assembled 16S rRNA seqeunces (unpublished data). Based on the full-length 
16S rRNA sequence, phylogenetic tree was created, including the two 
bacteria, which are linked to resistance and displayed them with bacteria of 
the gut bacterial community Altered Schaedler flora (ASF). The analysis 
revealed that the two candidate bacteria of the family Lachnospiraceae are 
distinct from each other, likely deriving from different bacterial genera (Figure 
3.15).   
 
 
Figure 3.15 - Phylogenetic tree of Lachnospiraceae spp. associated with protected 
phenotype. Phylogenetic tree from full-length 16S rRNA gene sequences of bacteria of the 
family Lachnospiraceae associated with resistance are displayed together with the eight 
bacteria of the Altered Schaedler flora (ASF). 
In summary, cohousing experiments with susceptible and resistant mice as 
well as subsequently, comparative analysis in non-cohoused susceptible 
(SPF-1) and resistant (SPF-2) mice could reveal that two unclassified bacteria 
of the family Lachnospiraceae are highly associated with enhanced resistance 
to C. rodentium at early time points of infection.  
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3.5 Discussion 
 
One of the major functions of the gut microbiota is to defend the host from 
invading pathogens, which is referred to as colonization resistance. The 
microbiota not only interacts directly with the pathogen, but also indirectly by 
activating the immune system and strengthening the epithelial barrier to inhibit 
pathogen colonization (Buffie and Pamer, 2013). An imbalanced microbiota 
composition increases susceptibility to infections (Doorduyn et al., 2006; 
Owens et al., 2008; Sekirov et al., 2008). Already at homeostatic conditions, 
the composition of the microbiota varies among humans, which could explain 
differences in susceptibility to infectious diseases. However, which specific 
intestinal bacteria are able to confer colonization resistance has not been 
comprehensively addressed.  
Citrobacter rodentium is a murine model for pathogens inducing A/E lesion in 
the gut epithelium such as the human pathogens EHEC and EPEC. The gut 
microbiota strongly affects the susceptibility to C. rodentium infections. For 
example, it has been shown that antibiotic treatment renders mice more 
susceptible to C. rodentium infections (Wlodarska et al., 2011).  
We hypothesized that recent advances in analytical and experimental tools 
would allow the identification and evaluation of distinct bacterial biomarkers to 
predict disease susceptibility to C. rodentium. First, by using isogenic mouse 
lines from different breeding facilities, microbial signatures were identified, 
which are associated with reduced susceptibility to C. rodentium. In the next 
step, cohousing experiments of resistant and susceptible mice confirmed 
specific bacteria associated with higher disease protection. 
C57BL/6N isogenic mouse lines from different breeding facilities were studied 
for differences in their microbiota composition. Distinct microbiota composition 
in each breeding facility could be identified. Differences in the microbiota 
composition were already observed at phylum level, e.g. ratio of Firmicutes to 
Bacteroidetes. Interestingly, mouse lines derived from the same breeding 
facility, but from different barriers, displayed a similar microbiota composition 
than mice from different breeding facilities. In addition, studied C57BL/6N 
mouse lines showed different kinetics of C. rodentium infection. For example, 
SPF-1 mice displayed higher luminal colonization of C. rodentium than SPF-2, 
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SPF-3 and SPF-7 mice at early time points (day 1 and 3 p.i.), whereas at later 
time points (9 p.i. and 14 d p.i.) SPF-1 mice started to clear the infection and 
showed lower luminal abundance of C. rodentium than SPF-2 mice.  
We identified that distinct features of the intestinal microbiota are associated 
with lower C. rodentium colonization in early phase of infection. Specifically, 
bacteria of the families Prevotellaceae, Ruminococcaceae, and S24-7 as well 
as unclassified bacteria of the order Clostridiales were positively correlated 
with higher resistance to C. rodentium infection. To exclude that different 
disease susceptibilities are explained by genetic differences reported in 
C57BL/6 mice due to different C57BL6/N sub-lines or acquired during 
inbreeding by spontaneous mutation, one susceptible (SPF-1) and resistant 
(SPF-2) mouse line were cohoused with germ-free C57BL/6NTac mice. Fecal 
microbiota composition as well as disease progression was highly similar in 
formerly germ-free mice as their respective cohousing partner, indicating that 
the phenotype is fully microbiota dependent. If potential genetic differences in 
other isogenic C57BL/6N lines could contribute to varying colonization 
susceptibility has to be evaluated. By using cohousing experiments of 
protected and susceptible mice, we identified different sets of bacteria 
associated with lower colonization: specific bacteria of the order Clostridiales 
(Eubacteriaceae and Lachnospiraceae) and of the order Bacteroidales 
(Rikanellaceae). Interestingly, two bacteria of the family Lachnospiraceae 
were also higher abundant in non-cohoused SPF-2 than non-cohoused SPF-1 
mice and therefore, represent strong candidates for conferring resistance to 
C. rodentium infection. Lachnospiraceae (phylum Firmicutes, class Clostridia, 
order Clostridiales) are a bacterial family in the gastrointestinal tract of many 
mammalians and include bacteria, which are strictly anaerobe (Gosalbes et 
al., 2011; Kittelmann et al., 2013). Some bacteria of the family 
Lachnospiraceae are butyric acids producer, a short chain fatty acid (SCFA), 
arising from microbial fermentation (Meehan and Beiko, 2014). Butyrate is a 
crucial energy source for other bacteria and colonic epithelial cells (Meehan 
and Beiko, 2014; Pryde et al., 2002). Interestingly, patients with inflammatory 
bowl disease exhibit a lower abundance of Lachnospiraceae (Clostridium 
subsets IV and XIVa).  
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Isolation of the two bacteria belonging to the family Lachnospiraceae that 
were associated with protection against C. rodentium is essential to 
characterize bacteria in more detail as well as to identify the contribution to 
confer colonization resistance. Moreover, transfer of isolates to susceptible 
mice is crucial to validate the association with protection.  
Strikingly, another study correlated resistance to C. rodentium infection with a 
decrease in bacteria of the order Clostridiales in NIH Swiss mice. (Willing et 
al., 2011). However, it has to be evaluated, if the transfer of the bacteria of the 
family Lachnospiraceae from our study also confers resistance in other mouse 
lines with different genetic backgrounds than seen in C57BL/6N  (e.g. 
C3H/HeJ, NIH Swiss).  
An important barrier to inhibit enteric pathogen colonization is constituted by 
the host epithelium and the associated mucus layer. For example, greater 
numbers of adherent C. rodentium attached to the cecum is higher in mice 
lacking a mucus layer (Muc2-/- mice) compared to wild type animals 
(Bergstrom et al., 2010). Mucus not only forms a physical barrier and reservoir 
for antimicrobial peptides, it also forms a distinct niche for commensal 
bacteria that use mucins and associated molecules as carbon sources 
(Johansson et al., 2011). Members of the order Clostridiales are localized in 
close proximity to the gut epithelium within the mucus layer and have been 
suggested to be critical regulators of the turnover of the mucus layer. Previous 
studies have indicated that bacteria of the order Clostridiales, i.e. Clostridium 
septicum, Clostridium perfringens, show mucolytic activity and metabolize 
mucus-derived oligosaccharides (Deplancke et al., 2002; Macfarlane et al., 
2001). Anaerobic fermentation of carbohydrates of the mucus layer by these 
bacteria results in production of SCFAs, which in turn increase mucus 
production and secretion (Burger-van Paassen et al., 2009; Finnie et al., 
1995). Similarly, treatment with the phytonutrient eugenol has been reported 
to confer resistance to C. rodentium infection by increasing inner mucus 
thickness (Wlodarska et al., 2015). In the same study eugenol treatment 
additionally augments abundances of bacterial families within the Clostridiales 
(Wlodarska et al., 2015). Therefore, mucus thickness has to be addressed in 
our analyzed isogenic mouse lines, which may explain varying susceptibilities 
to C. rodentium infections. Moreover, cohousing experiments of protected and 
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susceptible mice could reveal if specific transferred bacterial features (e.g. 
Lachnospiraceae) strengthen mucus barrier. 
Moreover, antibiotic treatment was shown to deplete butyrate-producing 
Clostridia, which enhance tissue oxygen allowing the expansion of 
aerotolerant Salmonella (Rivera-Chávez et al., 2016). If Lachnospiraceae are 
also important for preventing C. rodentium by lowering luminal oxygen level 
has to be addressed in the future.  
Besides the maintenance of the epithelial barrier, another key factor for 
conferring resistance against pathogen colonization is competition for 
essential nutrients and niches. For example, C. rodentium can be 
outcompeted by other γ-Proteobacteria, such as E. coli, which is accumulated 
in the gut upon infection (Lupp et al., 2007) and may occupy niches and 
compete for nutrients. Colonization of E. coli in germ-free mice reduces 
burden of C. rodentium, whereas Bacteroides thetaiotaomicron and 
Bacteroides vulgatus do not outcompete C. rodentium (Kamada et al., 2012). 
Under normal conditions, B. thetaiotaomicron can catabolize mono- and 
polysaccharides. However, if mice are fed a simple diet of monosaccharides, 
B. thetaiotaomicron reduces C. rodentium burden by competing for available 
monosaccharides (Kamada et al., 2012).  Strikingly, SPF-6 mice were the 
only studied mouse line showing abundances of commensal E. coli, which 
was decreased over time during infection excluding that in our microbiota 
settings E. coli is blooming during C. rodentium infection and confers 
resistance. It cannot be excluded and it is highly likely that other not yet 
identified commensal bacteria compete for nutrient availability with C. 
rodentium and therefore, conferring colonization resistance directly.  
Not only competition of nutrients influence pathogen colonization, but also 
metabolites derived from commensal bacteria can be exploited by the 
pathogen for enhancing virulence expression and proliferation. It has been 
reported that colonization of B. thetaiotaomicron resulted in elevated 
concentrations of succinate, which in turn, enriches expression of virulence 
genes of C. rodentium, e.g. genes important for A/E lesions, and therefore 
enhances pathogenicity (Curtis et al., 2014).  
Moreover, abundance of segmented filamentous bacteria (SFB) was 
observed to differ in isogenic C57BL/6 mice from different vendors. Increased 
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SFB levels have been reported to correlate with augmented resistance to C. 
rodentium via stimulation of CD4+ T helper cells and therefore, amplified 
production of IL-17/IL-22-RegIIIγ-axis (Ivanov et al., 2009). In our study, by 
using 16S rRNA sequencing, abundance of SFB was not different in 
susceptible (SPF-1) and resistant (SPF-2) mice. However, these data should 
be verified by using a SFB specific PCR.  
Translation to human research is important to generate new mucosal 
therapies. C. rodentium is a murine pathogen, which is used to mimic human 
pathogenicity of EHEC and EPEC in mice. C. rodentium possesses 
characteristic pathogenic features of EHEC and EPEC such as the formation 
of A/E lesions, including similar virulence factors, e.g. type III effector protein 
Tir and the bacterial outer membrane protein intimin (Petty et al., 2010; 
Schauer and Falkow, 1993). A/E lesions on the gut epithelium are crucial for 
proper colonization and virulence (Deng et al., 2003). In contrast to C. 
rodentium and EPEC, EHEC expresses additionally a shiga toxin (stx), which 
is responsible for intestinal damage and life-threatening systemic diseases 
such as renal damage (Nataro and Kaper, 1998). Therefore, EHEC have 
been responsible for severe outbreaks of diarrheal illness (Frank et al., 2011; 
Rangel et al., 2005). Since stx is absent in C. rodentium, the pathogen does 
not cause the same pathogenicity in mice as EHEC does in humans. Vice 
versa, infection with EHEC in mice does not recapitulate formation of A/E 
lesions or intestinal damage (Mohawk and O'Brien, 2011). To overcome these 
limitations and generate an improved model to study EHEC pathogenicity 
Mallik and colleagues have been developed an stx-producing C. rodentium 
strain (Φstx2dact) combining the ability to cause A/E lesions and stx-mediated 
inflammatory damage (locally and systemically) (Mallick et al., 2012). 
Evaluating the impact of the intestinal microbiota composition as well as the 
identified microbial signatures to stx-producing C. rodentium, which develop in 
mice pathogenicity similar to human EHEC infection, could provide valuable 
insights into the interplay of microbiota and EHEC infections in the future.  
In summary, by using isogenic mouse lines from different breeding facilities, 
we demonstrated that each mouse line displays a distinct microbiota 
composition, featuring different susceptibilities to C. rodentium. We could 
identify bacterial signatures associated with lower colonization of C. rodentium 
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at early time points of disease, such as two bacteria of the family 
Lachnospiraceae, representing novel and uncultured bacterial species. Proof 
of their protective properties and an understanding of how those bacteria 
confer resistance are still lacking. Therefore, isolation of the bacterial strains 
is a necessary step to validate the association and enable functional studies 
in the future.  
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Abbreviations 
 
 
 
A/E Attaching/effacing 
ANOVA Analysis of variance 
ASF Altered Schaedler flora 
  
BSL Baseline 
  
CFU 
Coh 
Colony forming units 
Cohoused 
C. rod Citrobacter rodentium  
  
EDTA Ethylendiamintetraacetat acid 
EHEC Enterohaemorrhagic Escherichia coli 
EPEC Enteropathogenic E.coli 
  
GI 
GF 
Gastrointestinal tract 
Germ-free 
 
Lac Lactose-fermenting 
LDA Linear discriminant analysis 
LEE Locus of enterocyte effacement 
LEfSe LDA effect size 
LB Lysogeny broth 
  
NaCl Sodium chloride 
NIH National Institutes of Health 
 
o.g. Oral gavage 
OTU Operational taxonomic level 
  
PBS Phosphate-buffered saline 
PCoA Principal coordinates analysis 
PCR Polymerase chain reaction 
p.i. Post infection 
  
Reg3 Regenerating islet-derived protein 
  
SCFA Short chain fatty acid 
SDS Sodium dodecyl sulfate 
SEM Standard error of mean 
SFB Segmented filamentous bacteria 
SPF Specific pathogen free 
Stx Shiga toxin 
  
T3SS Type III secretion system 
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TE Tris EDTA 
Tir Translocated intimin receptor 
Tris Tris(hydroxymethyl)-aminomethan 
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General conclusion and outlook 
 
More than 100 trillion microorganisms from estimated at least 1000 microbial 
species including bacteria, archaea, fungi and protozoans as well as their 
respective viruses colonize the human body (Qin et al., 2010). The collection 
of microbial populations found on a host is referred to as microbiota and form 
complex ecosystems. Microbes within these ecosystems are strongly 
interacting with each other, but also individually or as community with the 
host. The microbiota coevolved with the host and contributes to many 
physiological function of the host. It influences the development and 
regulation of the host immune system and protects the host against invading 
pathogens (Clemente et al., 2012). The microbiota mediates resistance via 
several distinct ways: Directly by competing for nutrients and ecological 
niches, indirectly or immune-mediated by strengthening the epithelial barrier 
and by inducing protective immune responses (McKenney and Pamer, 2015). 
Alterations in the microbiota composition may disturb the delicate host-
microbiota balance negatively impacting the host. Distinct microbial alterations 
have been associated to a broad range of human diseases such as obesity, 
type 2 diabetes, inflammatory bowl disease and neurodevelopmental 
disorders (Wu et al., 2015). But even in homeostatic conditions, the microbial 
composition of the microbiota differs strongly among humans (Lozupone et 
al., 2012). Besides genetic variations, environmental factors such as diet, 
antibiotic treatment and hygiene have a great impact on the microbiota 
composition (Round and Mazmanian, 2009). This could explain varying 
susceptibilities to enteric infections in humans. Indeed, antibiotic treatment 
has been associated with augmented susceptibility to enteric infections e.g. 
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Clostridium difficile and non-typhoidal Salmonella disease (Doorduyn et al., 
2006; Owens et al., 2008; Sekirov et al., 2008).  
By using germ-free mice and conventionally raised mice treated with different 
antibiotics, researchers have identified long time ago the importance of the 
microbiota in mediating resistance to enteric infections (Bohnhoff and Miller, 
1962; Carter and Collins, 1974).  However, research has since then largely 
focused on studying in detail pathogenic bacteria rather than beneficial gut 
bacteria. Only in the last decade, culture-independent high-throughput 
sequencing technologies have revealed the complexity of commensal gut 
bacteria and resulted in a shift of the focus of many microbiologist on studying 
intestinal bacteria and their interactions with the host and pathogens. 
However, by using high-throughput sequencing researchers associate 
bacterial communities to specific diseases rather than showing direct 
causality. Therefore, little is known about effects of individual members of the 
microbiota on enteric pathogens and host immune responses. However, this 
is crucial to develop mucosal therapeutics based on defined communities to 
reconstitute the intestinal ecosystem. Already now, transfer of whole 
communities derived from the stool of healthy persons to diseased patients 
offers an effective and therapeutic approach. For example, reconstitution of 
the microbiota by fecal transplantation is successfully used to cure recurrent 
C. difficile infection with an efficiency of over >90% (Bakken, 2009; van Nood 
et al., 2013).  
Although fecal transplantation is cost-efficient and effective, transfer of bulk 
bacterial communities harbors several risks factors and therefore, high 
regulatory hurdles. An example of the risk is the transfer of opportunistic 
bacteria or not yet identified pathogenic bacteria that are potentially harming 
the recipient or have unwanted consequences. Currently, the fecal transplant 
donor is screened before fecal transplantation to identify currently known 
pathogens, but because of the high costs associated the complete community 
is not screened in detail routinely. Therefore, the outcome and long-term 
success of fecal transplantation in recipients has not been assessed 
thoroughly. Moreover, the colonization and composition of the transferred 
community is based on host genetics of recipients and environmental factors 
such as diet and medical treatments, potentially causing different immune 
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responses in recipients than in donors. Therefore, it is of high interest to study 
intestinal bacteria, their interaction with other gut bacteria and pathogens as 
well as the activation of immune responses in disparate host genotypes. 
Administrating fully defined and reproducible mixtures of beneficial bacteria 
will be a more safe approach to treat enteric infections and also would simplify 
the approval process for bacterial transplantation. 
The main aim of the presented works was to identify intestinal bacteria 
contributing to enhanced resistance towards enteric pathogens as well as to 
characterized novel microbiota-modulated protective immune responses. To 
this end, C57BL/6N mice from different breeding facilities were used, which 
featured distinct microbiota compositions as demonstrated using 16S rRNA 
sequencing. Isogenic C57BL/6N mouse lines had different susceptibilities to 
the enteric murine pathogens Salmonella enterica spp. serovar Typhimurium 
and Citrobacter rodentium. Cohousing mice from different breeding facilities 
with isogenic germ-free C57BL/6NTac mice excluded any influence of the 
genotype on this phenotype and corroborated that differences seen in mice 
from different breeding facilities are microbiota-dependent. In both infection 
models microbial signatures correlating with increased resistance were 
identified, which differed in S. Typhimurium and C. rodentium infection.  
In case of C. rodentium, statistical analysis of 16S rRNA sequencing data 
revealed that two bacterial species of the family Lachnospiraceae were linked 
to lower susceptibility to C. rodentium. These results are currently only based 
on culture-independent approaches, enabling to establish a strong 
association, but no direct causality. Therefore, isolation of bacterial 
candidates will be crucial to validate the association and to identify in more 
detail the mechanisms involved in conferring resistance. As next steps, 
metabolomic profiles of the two bacterial species could help to identify direct 
nutrient interaction with C. rodentium inhibiting pathogen growth in vivo. 
Moreover, it has been reported that higher mucus thickness lowers 
susceptibility to C. rodentium (Bergstrom et al., 2010). In turn, properties of 
the mucus barrier are dependent on the microbiota composition (Jakobsson et 
al., 2015). It would be interesting to characterize if the two bacteria of the 
family Lachnospiraceae affect mucus barrier thickness and therefore, 
indirectly lower susceptibility.  
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In case of S. Typhimurium infection, bacteria of the families S24-7 and 
Prevotellaceae as well as the family Verrucomicrobiaceae were associated 
with increased resistance. Transfer of 11 bacterial strains, cultured from feces 
of resistant mice, was able to phenocopy the resistant phenotype in previously 
susceptible mice. Cultured bacterial strains included members of the families 
Prevotellaceae, Bacteroides, S24-7, Lactobacillaceae and Lachnospiraceae. 
However, it is unclear if a single bacterial strain or the complete community is 
responsible for conferring resistance. In addition, the stability of transferred 
bacterial strains in the intestinal microbiota conferring resistance has to be 
addressed. Moreover, in this study microbiota-induced interferon (IFN) γ, 
produced by CD4+ T cells in the LP was identified as one novel key factor for 
controlling Salmonella loads in the mucosal tissue. IFNγ signaling has been 
reported to activate different microbicidal mechanisms enhancing killing of 
infected macrophages and augment T cell responses (Foster et al., 2003; 
Gordon et al., 2005; Kaiser et al., 2012; Nairz et al., 2008). In addition, 
Interferon-γ has been described to contribute to mucus excretion by goblet 
cells of Salmonella-infected mucosa (Songhet et al., 2011). Downstream 
pathways of microbiota-induced IFNγ, which are involved to lower pathogen 
loads should be studied in the future.  
In both studies, in vivo experiments with mice were used to ensure similar 
genotypes as well as environmental conditions such as diet and medical 
treatments allowing functional and mechanistic research. Mice and humans 
share a similar physiology and immunological features. Therefore, animal 
models are increasingly used to study functional as well as mechanistic 
research in a controlled experimental defined setup. Especially in the 
microbiota research, mouse models are widely used because of simple 
manipulation and intervention of the microbiota as well as relatively low 
maintenance cost and short life cycle. Moreover, animal experiments have the 
advantage to collect easily samples before and during disease as well to 
manipulate simply the microbiota to admit assessing causality in microbiota-
associated diseases. Nevertheless, the human and murine microbiota show 
differences in their relative abundances of intestinal bacteria (Nguyen et al., 
2015; Xiao et al., 2015). However, high similarity at the functional level of the 
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murine microbiota to its human counterpart was observed using metagenomic 
analysis (Xiao et al., 2015). In most of the cases, human studies have the 
limitations to establish only correlations but not causality. Currently, also 
human microbiota-associated (HMA) mouse models have been started to be 
used. To establish HMA mice, fecal stool samples from humans are 
transferred to germ-free mice. By transferring the human microbiota, several 
human diseases could be modeled in mice (Arrieta et al., 2015; Koren et al., 
2012; Ridaura et al., 2013). However, if HMA mice are a good tool to study 
infectious diseases has to be evaluated in the future as mice and humans 
differ in several characteristics, which makes translational research from 
mouse to human challenging. 
In summary, identification and isolation of specific members of the microbiota 
that are conferring resistance is essential for engineering the microbiota in the 
future. Transferring stable, well-characterized bacterial communities would 
offer an effective and cost-efficient method to lower susceptibility to enteric 
infections. In addition, a well-studied bacterial community allows minimizing 
the transfer of potential harmful commensal bacteria.  
In the meantime, collecting stool samples from healthy patients, identifying 
their microbiota composition and storing them in a stool bank could simplify 
screens for potential donors as to eventually transfer only material from 
donors with similar genetic and environmental  (e.g. diet, medical treatments) 
backgrounds to enhance stability of the transferred bacterial community. Until 
now, identifying in detail a complete fecal microbiota and the genotype of the 
host in a cost-efficient way is challenging.   
In summary, the microbiota has a high potential as therapeutic target for 
enteric infections, but also for other common diseases such as obesity, 
diabetes and inflammatory bowl disease. While we and others provided novel 
insights into the complex interplay between the microbiota and the host, there 
is still a long way to go before distinct intestinal bacteria can be used as a 
safe and effective drug.  
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